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“One thing I have learned in a long life: That all our science, measured against reality, is primitive and childlike 
– and yet it is the most precious thing we have.”  
 
“Bear in mind that the wonderful things you learn in your schools are the work of many generations. All this is 
put in your hands as your inheritance in order that you may receive it, honor it, add to it, and one day faithfully 
hand it on to your children.”  
Albert Einstein, 1897–1955 
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ABSTRACT   
Background Stress-related disorders including clinical burnout (CB) are one of the main 
causes of sickness absenteeism in many Western countries. Little is known about the situation 
of CB patients, and objective markers are not used as an aid in clinical work with these 
patients. Moreover, evidence-based treatments are scarce to date. Yoga has shown an effect 
on stress, depression and anxiety, and might be an interesting treatment alternative. 
 
Aims To understand the situation of patients with CB on sick leave (CBG), to investigate the 
effect of traditional yoga (TY) on patients with CB, and whether there are subjective and 
objective measures that can be used for screening, to diagnose CB, to follow the course and 
evaluate treatment effects.  
Subjective measures  
1. To describe health-related quality of life (HRQoL) in the CBG at baseline and compare to 
a healthy control group experiencing stress (HCG). 2. To explore the effect of psychological 
treatment with TY, mindfulness-based cognitive therapy (MBCT) and cognitive behavioural 
therapy (CBT) on HRQoL in the CBG. 
Objective measures 
1. To evaluate potential biomarkers for screening, diagnosis, to follow the course and to 
evaluate treatment effects in patients with CB on sick leave. 2. To compare the concentration 
of biomarkers in the CBG at baseline with that of biomarkers in the HCG at baseline. 3. To 
evaluate whether the 1 µg ACTH test can be used as a stress test. 
 
Material and methods This thesis comprises 4 publications, derived from two randomized 
clinical trials (RCTs). Study population 1: The CBG, primary care patients (n=94, 12 men). 
Randomized to TY, MBCT or CBT. They received 20 weeks of group treatment, three hours 
per week, with additional homework for a minimum 4.5 hours per week. HRQoL was 
measured using SWED-QUAL questionnaire (S-Q). S-Q and biomarkers in blood and urine 
were sampled before and after treatment. Study population 2: The HCG, health care 
personnel (n = 88, 16 men). The HRQoL and biomarker baseline measurements for the HCG 
were used for comparison. HCG also provided data from the ACTH stimulation test. Article I 
presented a descriptive and comparative study of HRQoL at baseline. In Article II we 
explored the treatment effect of TY, CBT and MBCT measuring HRQoL pre- and post-
treatment. Article III presented a hypothesis-generating and comparative study exploring 
biological markers in blood and urine for potential use as tools for screening, diagnosis, to 
follow the course and evaluate the treatment effects. Article IV presented a methodological 
study in which we explored whether the 1 µg ACTH stimulation test could be used as a tool 
to assess the capacity to respond to stress. 
Results Subjective measures: (I) HRQoL in the CBG was low in general, and significantly 
lower in most subscales compared to the HCG. (II) Several S-Q subscale scores were 
normalized after treatment in all groups. Differences between the treatment groups were 
found in favour of TY and MBCT with a small effect size (ES). Objective measures: (III) All 
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biomarker concentrations were within the normal range at baseline in CBG. Compared to the 
biomarker concentrations in the HCG, the concentrations of the urinary hormones 
epinephrine, norepinephrine, dopamine, 5-hydroxyindoleacetic acid were significantly 
higher, while urinary cortisol concentrations were significantly lower. When comparing pre- 
and post-treatment concentrations for each treatment and for all treatments calculated 
together, testosterone and urinary epinephrine showed a significant decrease, while, estradiol 
showed a significant increase. (IV) The intravenous 1 µg ACTH stimulation test showed that 
the highest cortisol concentrations after injection were found at 30 and 40 min, and that the 
concentration curves for cortisol in serum and saliva were parallel at 30 and 40 min. 
Conclusions In severely ill patients on sick leave and diagnosed with CB, ICD-10 code 
F43.8, subjective measures (HRQoL) showed a global decrease. After treatment small 
differences in effect size between groups were seen in several subscales, in favour of TY over 
MBCT and CBT, indicating differences in treatment effects. All groups showed large, 
significant improvements after treatment in HRQoL, presumably at least partly due to the 
treatments. Objective measures (biomarkers) showed potential biomarkers for screening and 
diagnosis (urinary catecholamines, urinary cortisol and 5-hydroxyindoleacetic), to follow the 
course and evaluate treatment effects (testosterone, estradiol and urinary epinephrine), and 
these warrant further investigation. The ACTH test could be a potential stress test, measuring 
the maximum concentration of cortisol in saliva after 1µg IV ACTH after 30 and 40 minutes 
solely. TY seems to be of interest to explore further for treatment and prevention. HRQoL 
and biomarkers can be used for screening and to follow the course, and warrant further 
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1 BACKGROUND 
1.1 Burnout  
Work-related stress, including clinical burnout (CB), has for decades been a problem in many 
Western countries, resulting in increasing societal costs [1], and is today one of the leading 
causes of sickness absence in Sweden [2]. Persons experiencing CB have mostly been young 
to middle-aged women; however, the number of men affected is increasing [3]. It inflicts 
great suffering, with enormous indirect and direct costs at all levels of society, and it is still 
increasing [2, 4]. The concept CB has no clear definition [5], and so far no objective markers, 
i.e. biomarkers, are in use to aid in screening, diagnosis, following the course and evaluating 
treatment efficacy [6]. Evidence-based treatments are still scarce, although isolated studies 
have shown some effect on symptoms and return to work [7]. The course of clinical burnout 
is often long and many patients never fully recover [8]. Few random clinical trials (RCT) 
have been conducted in this patient group [7, 9, 10], and there is an urgent need for more 
knowledge on CB, a clear conceptualization, potential markers and suitable treatments. 
Although the term/word burnout had been used previously in literature [11, 12], and a 
condition similar to burnout has been described in for example the Bible [13], and more 
recently in the novel Buddenbrooks [14], the concept of burnout was first coined by 
Freudenberg in 1974 in volunteers working with persons with drug addictions [15]. Shortly 
after Freudenberg coined the concept, Maslach, Jackson and Leiter wrote about burnout and 
also constructed the Maslach Burnout Inventory (MBI) [16, 17]. Their theory was that 
burnout develops as a result of the workplace situation. MBI measures the main components 
in burnout according to Maslach, i.e. cynicism and detachment, a reduced sense of personal 
accomplishment at work, and emotional exhaustion. The MBI is the questionnaire most often 
used in research. The MBI has no established cut-off level for burnout, which makes it 
difficult to use in a clinical setting. Other questionnaires, e.g. Shirom Melamed burnout 
questionnaire, have been used in previous research and have shown correlation with the ES 
diagnosis, but no cut-off level has been established yet [18].  
As a diagnosis, burnout is not new, nor is it a new phenomenon. Previously the diagnosis 
neurasthenia was used, originating in the late 19th century and describing main features 
similar to burnout [5]. Burnout was initially a concept used by the social sciences, and not for 
diagnosis [5]. Later, studies on burnout have developed along two different lines; one 
focusing on treatment and one on the academic aspect, dealing with the underpinnings of 
burnout. Despite much research, the international scientific community has not yet 
established a clear definition and commonly accepted conceptualization [5]. 
In medicine, the need for a better understanding of burnout per se, diagnostic criteria and 
objective markers as well as the need for potential treatments, has been a driving force for 
research. The term CB is used frequently and in some countries, such as Sweden, Norway, 
Finland and the Netherlands, patients can be sick-listed for CB, but Sweden is the only 
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country using specific diagnostic criteria [5, 19, 20]. This is in part due to the need to qualify 
for sickness benefits as well as the need for diagnostic tools. In 2004, the National Board of 
Health and Welfare in Sweden established the diagnostic criteria for exhaustion syndrome 
(ES), ICD-10 code F43.8A (Table 1), which is used for CB in the Swedish context [8, 21]. In 
a recent study the diagnosis of ES was found to be the diagnosis which best corresponds to 
CB [22]. ES is characterized by emotional and physical exhaustion that cannot be restored by 
rest, cognitive disturbance, sleep disorders, emotional instability, difficulties with demands 
and physical symptoms like palpitation, dizziness or sensitivity to sounds (Table 1). The main 
features of ES with emotional and physical exhaustion correspond well to the main criteria of 
MBI [16]. In this thesis the term CB will be used for these patients. The course of CB tends to 
be long and many do not fully recover, or will live with a long-standing heightened 
sensitivity to stress, and relapse is common [19, 23]. There is no generally accepted clear 
definition of CB, which differs depending on the context and country [5]. It is also referred to 
by numerous names such as stress-related exhaustion disorder [22], chronic stress-induced 
exhaustion [7], chronic burnout syndrome [24], job-stress related depression [25] and 
neurasthenia [26]. Before ES was established in ICD-10, the code Z 73.0 was sometimes used 
to reflect “problems related to life management difficulty”, but Z codes do not use diagnostic 
criteria and thus are less useful in a clinical setting. Furthermore, it is difficult to compare 
findings from patients diagnosed with Z 73.0[21]. The cause and a cure of CB have not yet 
been fully elucidated. Several theories have been proposed with different foci, both external 
and internal. Nonetheless, many agree on the definition that the resources of an individual do 
not meet the perceived demand [27, 28]. Long-standing stress exerts an effect via several 
pathways. First, stress affects the hypothalamic-pituitary-adrenal (HPA) axis and also the 
autonomic nervous system (ANS) [29]. It is not known why some persons are more 
susceptible, but performance-based self-esteem [30, 31] and genetic factors [32] have been 
found to have an impact. Research has also shown that sleep is a crucial factor for the 
development, maintenance and improvement of CB [33, 34], and that both work and personal 
factors contribute to CB [32, 35]; this is in concordance with the diagnostic criteria for ES. 
Furthermore, lowered self-efficacy [34] is also an important factor together with disturbed 
recovery [36-38], and occupational balance [39]. External factors, such as societal changes, 
downsizing in companies, resulting in very lean organizations with little extra capacity to 
handle unexpected events such as sick leave, have also been found to have an impact [40, 41]. 
Discussion is still ongoing as to whether CB is a separate diagnosis or is a form of depression 
[42]; nevertheless, today most agree that CB is a diagnosis in its own right, but that 
comorbidity with both anxiety and depression is common [7]. The main challenges for 
patients with ES are usually mental and physical exhaustion, and to lesser degree symptoms 
of depression. There is also a considerable overlap with other depression and anxiety 
diagnoses, myalgic encephalomyelitis/chronic fatigue syndrome, fibromyalgia, diabetes 
mellitus, hypothyroidism, chronic obstructive pulmonary disease, tick-borne encephalitis 
which must be ruled out before ES can be considered [43]. 
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Table 1 Diagnostic criteria for exhaustion syndrome, ICD-10 code F43.8A.  
A Physical and mental symptoms of exhaustion with minimum 2 weeks duration. The symptoms 
have developed in response to one or more identifiable stressors which have been present for at 
least 6 months 
B Markedly reduced mental energy which is manifested by reduced initiative, lack of endurance, or 
increase of time needed for recovery after mental efforts 
C At least four of the following symptoms have been present most of the day, nearly every day, 
during the same 2 week period: 
 a Persistent complaints of impaired memory 
 b Markedly reduced capacity to tolerate demands or to work under time pressure 
 c Emotional instability or irritability 
 d Insomnia or hypersomnia 
 e Persistent complaints of physical weakness or fatigue 
 f Physical symptoms such as muscular pain, chest pain, palpitations, gastrointestinal problems, 
vertigo or increased sensitivity to sounds 
D The symptoms cause clinically significant distress or impairment in social, occupational or other 
important areas of functioning 
E 
 
The symptoms are not due to the direct physiological effects of a substance (e.g. abuse of a drug, 
a medication) or a general medical condition (e.g. hypothyroidism, diabetes, infectious disease) 
Translation from Glise et al., 2012. 
1.2 Health, definition and policies for its promotion  
Everybody wants to live a satisfactory life – with good health. The definition of health has 
changed over the years, and in 1984 the WHO introduced a new concept in which health is 
defined as “a resource for everyday life, not the objective of living” [44]. Moreover, health 
promotion is not just the responsibility of the health sector but goes beyond healthy lifestyle 
to well-being. Most countries have policies for promotion of health and quality of life (QoL), 
which also comprises health related QoL (HRQoL). In Sweden the government described the 
work for good and equal health as “a process which gives people possibilities to increase the 
control over and promote their health” [45]. 
In ancient times, Hippocrates and Galenos had a holistic view of health, which included both 
body and mind [46, 47]. Later, there was a division between these entities and subsequently 
the biomedical health definition was introduced [47]. Since then, enormous medical 
achievements have been made, especially in acute conditions. Recently, we have returned to a 
holistic approach to health and what a human being is. Much research is ongoing, and we 
have started to reveal the intricate interplay between body and mind, the differences in bodily 
functions and the ways to process and metabolize drugs, for example, with more 
individualized personal treatments. Moreover, people are highly flexible, and have more 
capacity to develop with different types of training, e.g. for psychiatric disorders such as 
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depression and anxiety. In addition, today we have the societal resources, a stable foundation 
due to long-term peace, economic resources and an increased understanding of psychiatric 
illness. 
We have a highly sophisticated healthcare with advanced treatments and cures, and many 
more patients go through complicated surgical procedures, and also at a higher age. We live 
longer, both healthier and with severer diseases than ever before. Many patients live with 
chronic diseases, and with diseases that were previously incurable. We have advanced from a 
situation where survival and cure were the endpoints in research and clinic, to a situation 
where HRQoL has become increasingly important, after treatment or when living with 
different diseases, to such an extent that the goal in today’s healthcare is the best possible 
HRQoL for patients with chronic diseases, after treatment or procedures and when on 
medication [48] .  
One way of increasing HRQoL and coming closer to the health goals described by the WHO 
and governments around the world, is lifestyle interventions. Lifestyle interventions have 
become more and more interesting as an increasing number of positive effects have been 
demonstrated. Furthermore, medicines alone cannot address many of the health issues we 
face today when living with chronic diseases and after serious illness. Lifestyle interventions 
cannot be replaced by medicine – the effects of the two systems complement each other – and 
many lifestyle changes can be implemented by people by themselves. Although lifestyle is a 
broad concept without a clear definition, common aspects include having a good balance 
between activity and recuperation, sufficient sleep, healthy food, physical exercise, a non-
sedentary life, “normal” weight, no smoking and a moderate alcohol. Yoga has been used as a 
lifestyle intervention for many years, and many yoga practitioners, both healthy and those 
living with disease, have described a good overall effect as well as an effect on specific 
symptoms such as stress, anxiety and depression [49]. Furthermore, yoga is a traditional 
system that has been used for many years to improve health and inner balance in the 
individual. Many patients today have a keen interest in how their mind and body function, an 
increasing wish to manage their situation themselves, and to be involved in their own 
treatment which is recommended [50]. They want to lower the risk of becoming ill and to 
avoid side effects of medication, for example in cancer treatment. Healthy individuals want to 
maintain their health throughout life and prevent the onset of disease. For this, methods such 
as yoga which can be practised freely, individually and in group are required, which can be a 
good base for future treatments if needed. Many persons are also interested in exploring 
whether yoga can be used more specifically as a treatment for, for example stress-related 
disorders.  
1.3 Stress and the development of the concept of stress 
Stress is an inevitable part of human life and the driving force of all human development, yet 
too much stress without proper recovery can lead to ill health, sick leave, disease and even 
death [51, 52]. Stress can be defined as anything that challenges our capacity and disturbs our 
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inner balance, our homeostasis. In the very beginning, the one-cell organism contracted and 
expanded as a reaction to stress in the form of light and darkness. Cold, heat, starvation, 
trauma, and attack are well-known stressors, as well as psychological stress, all exerting an 
impact on the individual[53]. Moreover, all positive events also cause stress. Claude Bernard 
wrote: “All the vital mechanisms … always have one purpose, that of maintaining the 
integrity of the conditions of life within the internal environment” [54]. Walter Cannon 
further developed these ideas into the concept of homeostasis. He also developed the 
concepts of the “fight or flight response” and the sympathetic-adrenal system, which are 
important in the understanding of stress [55, 56]. The fight or flight response means that you 
can react in two different ways when you are under attack; either fighting or fleeing. He also 
showed the importance of adrenaline in the stress response and for maintaining the 
equilibrium of homeostasis. Hans Selye introduced the expression stress and the concept of 
general adaptation syndrome [57]. Later, Mason argued that the role of emotions in stress 
reactions needs to be taken into account, which is in line with today’s concept of stress [58]. 
When we relax on a daily basis, stress is not considered a problem, and yoga has shown to be 
an efficient tool for this [59].   
In the development of CB two major stress systems are involved; the HPA-axis and the ANS 
[29, 60]. Much research is based on measuring cortisol, which is the end product when the 
HPA axis is stimulated [61]. Cortisol induces numerous changes in the body to prepare us for 
fight or flight; and is thus a potential marker for stress. Measuring cortisol concentration as an 
indicator of chronic stress has shown inconsistent results. This is probably due to a difference 
in time points when sampling. Initially when stressed, the concentration of cortisol will be 
high, returning to normal slowly, while with prolonged stress the concentration will be low 
with an insufficient response to stress [25]. Thus, it is crucial when interpreting results to 
know where the patient lies on the stress timeline [62-64]. Previous research has shown 
problems generating a sufficient cortisol response in the corticotrophin-releasing hormone 
(CRH) test after Dexamethasone pre-treatment. Decreased cortisol concentrations after the 
test were still present at follow-up 7 years later [25, 65]. The sympathetic nervous system 
(SNS) and the parasympathetic nervous system (PNS) constitute the ANS, which is another 
system involved in the stress response. The ANS governs our inner organs and can only 
partly be influenced by our will [29]. Respiration rate, heart rate, digestion and papillary 
response are functions regulated by the ANS. The SNS and PNS usually counteract each 
other, i.e. in stressful situations the SNS is active, but using techniques that stimulate the 
PNS, the influence of the SNS diminishes. SNS can be described as a system which induces 
fast mobilization of resources, for example for fight, while PNS is a dampening system, 
which is more slowly activated. Respiration, an important factor in yoga practice [49, 66, 67], 
is one of the ANS functions that can be influenced by will. Furthermore, heart rate and blood 
pressure can be indirectly influenced by a change in the respiratory rate [66].  
CB has been shown to induce changes in biomarker concentrations; nonetheless, biomarkers 
are not used in clinical practice [6, 68, 69]. Furthermore, CB has been shown to alter brain 
structures and function compared to healthy individuals [22, 70-73]. In imaging studies, 
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patients with CB exhibit dorsolateral prefrontal cortex thinning as well as thinning in the 
anterior cingulated cortex and left superior temporal gyros. Furthermore, changes in volume 
were found, with reduction of caudate and putamen volumes in the basal ganglia. In the 
patient group, perceived stress correlated with  the reduced volumes of caudate and putamen, 
indicating causality [70]. Reduced volumes of caudate and putamen are involved in impaired 
cognitive functions such as attention, memory and executive functions. These findings 
resemble those found in persons with major life trauma which involves severe stress per se 
[70, 74]. Moreover, the thinning of grey matter in the prefrontal cortex and the altered 
functional connectivity are associated with impaired top-down regulation, i.e. an impaired 
ability to down-regulate negative emotions caused by, for example stress [71]. The cognitive 
impairments are often long-lasting, for months and even years. Some, but not all changes 
seem to be reversible in ES patients. A recent MRI study showed that the changes in the 
prefrontal cortex returned to normal together with a normalized caudate volume, while the 
increased volume of amygdala and the thinning of cortex of the left superior temporal gyrus 
seen, were unaltered after CBT treatment combined with breathing exercises, and full RTW 
in a group of ES patients [73]. Furthermore, the study indicated a correlation with perceived 
stress as well as increased vulnerability to stress in women. The follow-up MRI in this group 
was made approximately 2–4 years after the onset of ES. This highlights that in this severely 
sick group of patients some changes in cerebral areas involved in processing stress, are 
longstanding and even may persist [71, 73]. A recent study showed that the right amygdala, 
which is involved in stress processing, decreases in volume with the practice of yoga and 
meditation, and yoga might thus be a possibility to help these patients.   
1.4 Measures 
1.4.1 Subjective measures – HRQoL 
Self-assessed QoL, which also comprises health-related quality of life (HRQoL), is known to 
reliably reflect the patient’s situation [75]. This has made HRQoL increasingly popular, and 
many studies today use HRQoL as an outcome variable, alone or in combination with other 
measures, for example biomarkers. Information on HRQoL can be used to improve 
healthcare and decrease healthcare costs [48]. Burnout has been shown to have an impact on 
HRQoL in different groups, with lower scores the more severe the condition [76]. HRQoL in 
psychiatric patients and in patients with somatic diseases with psychiatric comorbidity have 
shown generally low scores [77, 78]. The reduction in HRQoL scores results from the 
symptoms and the reduced self-perceived abilities reported when filling in HRQoL 
questionnaires and seeing healthcare providers. The HRQoL questionnaire the Swedish 
Health-related Quality of Life questionnaire (SWED-QUAL) is comprised of subscales 
including sexual function and social interactions, which need to be explored to gain a broader 
picture of the situation in groups of patients such as those with CB [79]. Few studies were 
found that explored HRQoL in these severely ill patients diagnosed with CB [80]. 
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1.4.2  Objective measures – Biomarkers 
Potential biomarkers for screening, diagnosis, following the course and evaluating treatment 
effects were used as another outcome. Biomarkers in burnout have been of interest for a long 
time [6, 68, 81]. Objective markers are not currently used but could improve the possibilities 
to screen for and to diagnose CB, as well as to follow the course and to evaluate treatment 
effects. Few previous studies have been conducted on a uniformly diagnosed group of these 
severely ill patients. Furthermore, few randomized control trials (RCTs) have been conducted 
using well-defined treatments in the same patient group. We therefore wanted to explore the 
concentrations of biomarkers at baseline and to evaluate the change after treatment. The 
biomarkers were mainly those that have shown a change in previous stress research or in 
research on yoga or psychological research. In the Hatha yoga pradipika, one of the most 
important yoga texts, hormones and especially testosterone are said to be able to be regulated 
by pranayama and asanas [82]. 
1.4.3 Objective measures – Stress test 
No stress test with measurement of cortisol is currently in use, but it might aid in diagnosis 
and evaluation of treatment effects. In psychosocial tests like the Trier Social Stress Test 
there is a habituation when repeated, which makes the test unsuitable in this setting [83]. 
Physiological tests, such as the insulin tolerance test, or the ACTH stimulation test used for 
diagnosing a cortisol deficiency, could be a possible alternative stress test in this setting. 
1.5 Yoga  
Yoga in the West, both the traditional and the many variations, have become increasingly 
popular over the last few decades as a means of improving and sustaining physical, mental 
and emotional well-being [84, 85]. Moreover, yoga has been listed by UNESCO as an 
intangible cultural heritage of humanity since 2016 [86]. The term yoga is a Sanskrit word 
meaning unification between the human spirit and the divine [87]. TY advocates a holistic 
approach to individual existence which functions as a single entity. TY is based on training to 
balance the “Deha” in order to develop a stable ground for meditation [82]. The Sanskrit term 
“Deha” means body, and as such comprises all parts of an individual: physical, mental, 
emotional and spiritual. The word spiritual denotes here a sense of an all-pervading feeling of 
benevolence.  
In the West, we have generally applied 1) the physical aspect of the yoga practice, such as 
asanas (different physical movements and postures), and 2) pranayama (breathing exercises) 
and today 3) mental practices like meditation are more emphasized. Modern yoga tradition 
generally employs all three types of practices together. 
The traditional yoga employed in this thesis is a gentle form of Ashtanga yoga and is 
practised by observing the original principles [82], which are:  
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 Performing gentle, slow movements, without much effort, respecting the body and 
breath, and not trying to change the breath. 
 
 Slow breathing through the nose simultaneously with the movement. 
 
 Trying to find the equilibrium within the stance or posture. 
 
 Performing the exercises consciously, trying to be aware of the body, the movement 
and posture or stance while performing. 
 
 Pausing in between the exercise repetitions, and trying to experience the effect on the 
body, emotions and feelings with an open mind that is non-judgemental and 
accepting. 
 
According to yoga philosophy, human disease, in Sanskrit “Vyahdi”, is considered to be 
caused partly by an imbalance of the three “Dhatus” or elements, known as Kapha, Vata and 
Pitta. In other words, disease occurs when one of these is in excess of that required. 
Furthermore, an imbalance in “Prahna”, the vital energy that is regarded to be the sole cause 
of life, also contributes to disease [88]. 
An overarching principle in TY is similar to the idea of the self-healing capacity in medicine, 
in that TY philosophy on disease also states that TY uses this inherent self-restoring capacity 
[89]. Different physiological effects as well as the Western medicine placebo effect are 
utilized in yoga treatment. Another principle is that the yoga practitioner’s awareness should 
be hold in the affected area, for example after trauma or pain in the knee, which is considered 
to stimulate the healing process [82]. 
Yoga when used as a treatment employs either individualized instructions or standardized 
protocols, as in this study [82]. Furthermore, each person performs the programme in a 
certain sequence. The yoga therapist strives to find the minimum of exercises to bring about 
the desired effect using synergistic effects from the exercises. Not only the exercises 
themselves but the order in which they are performed are important, in that one exercise will 
enhance the effect of the next [82, 90]. Furthermore, some aspects of the treatment will aim at 
a specific level, such as working on the cause of the illness, together with exercises that work 
at a more general level, to alleviate symptoms. This will indirectly have an impact on the 
cause. For example, in anxiety some asanas may be given targeting the cause, while 
relaxation may alleviate the symptoms. Over time, the repeatedly experienced relaxed state 
may have an indirect influence on the cause of the anxiety. 
In TY practice it is said that 1% is theory, and 99% is training, which means that the person 
should understand why they are doing the exercise, and then try to understand what it means 
to them in their life, or situation, through their own experience while practising. 
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In the living yoga tradition in India, all types of yoga exercises are considered to have a 
medical effect if the previously mentioned principles are followed. This is irrespective of 
type, school or branch of yoga and whether it includes asanas, pranayama or meditation [91]. 
Yoga has proved to have an effect on hormones and stress markers [92-94], stress markers, 
mood, cognitive impairments, depression [95], anxiety [96, 97], stress [49, 98, 99], and on 
HRQoL, although not in our diagnosed patient group [100]. Furthermore, yoga has been used 
for rehabilitation after, e.g., acute myocardial infarction [101]. There is an increasing body of 
research, primarily on meditation, with results that are also considered applicable to 
movement-based contemplative practices like yoga. The yoga movements and postures 
together with the breathing exercises and meditation are thought to influence the nervous 
system, and to have multiple effects on various brain functions such as cognitive performance 
[102], emotion regulation [103], neuroplasticity [104], self-awareness [105], and attention 
modulation [106]. Thus yoga can be a plausible new treatment for cognitive improvement for 
this group of patients with cognitive impairments. Moreover, yoga has been shown to be 
neuroprotective [107], with a better effect the longer the duration of yoga practice. Yoga has 
also been shown to improve neuroplasticity [104]. Neuroplasticity is the brain’s ability to 
rewire, the ability to reorganize itself, both physically and functionally due to behaviour, 
thinking and emotions, and it aids in changing and creating new behaviours. Furthermore, it 
is essential in promoting initiative and activity in depression, for example, in which patients 
often suffer from procrastination, the avoidance of doing a task by a given deadline.   
In a longitudinal MRI study using mindfulness-based stress reduction, which includes asanas 
(physical postures) and meditation, the perceived stress decreased together with the density of 
the right baseolateral amygdala grey matter and improvements in the psychological state 
[108]. A meta-analysis of meditation, compiling results from MRI studies, showed that 
meditation-activated brain areas were involved in processing self-relevant information, self-
regulation, focused problem-solving, adaptive behaviour and interoception. In expert 
meditators, meditation induced functional and structural brain modifications especially in 
self-awareness and self-regulation [105]. In regular long-term practitioners MRI revealed 
grey matter volume differences in the left hippocampus with a greater volume found in areas 
governing executive functions, specifically working memory, which has previously been 
shown to improve with yoga practice [105]. 
 
Yoga has been introduced in healthcare and programmes using for example mindfulness-
based stress reduction, which also includes asanas (physical postures) and meditation [109], 
and yoga is used together with lifestyle interventions for patients with coronary 
arteriosclerosis [110]. 
Breathing is important for assimilating oxygen and to help eliminate the waste products from 
bodily processes, primarily carbon dioxide. Calm and deep breathing helps in this process. 
Oxygen is crucial in most processes in metabolism, and shallow breathing fills the respiratory 
tract only with approximately 0.2–0.5 L, but does not fill the entire lungs fully. This affects 
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the bodily functions, making them work less efficiently. It creates an overload to which the 
body tries to adjust, which is demanding and a form of stress. When breathing through the 
nose as in TY, the incoming air blends with nitric oxide formed in the sinuses. Nitric oxide 
dilates the blood vessels in the lungs and lowers the pulmonary artery resistance, which helps 
to take up more oxygen in the blood [111], which may further reduce the rate of breathing. 
Calm breathing makes the mind and body calm and reduces the stress experienced through an 
increase activation of the PNS [112]. Slow breathing, which uses more of the pulmonary 
capacity, and with a longer exhalation phase, has been shown to have multiple effects 
mediated through the PNS. In a recent study compiling the physiological evidence, the 
authors concluded that the effect of yoga is a result of activating the vagus nerve through 
calm breathing [112].  
In medicine we know that our physical body has innate restorative capacities, capacities to 
adjust and repair. Bone heals after a fracture, and most wounds heal by themselves. Many 
infectious diseases and skin conditions get better over time. The body adapts, adjusts and can 
find new ways of functioning with the new condition. When something threatens/changes the 
homeostasis, the body reacts to restore the inner balance or, if this is not possible, to find 
another level of homeostasis. The body tries to find the resources from within and to support 
the parts or functions that need reinforcement for survival. We can even generate new nerve 
cells, which were previously considered to be impossible [113]. Several restorative and 
healing processes are known and have been delineated, but many are still unexplained; they 
are often called placebo or expectation effects [114]. 
TY works through additional physiological effects, besides the breathing. For example, the 
gentle movements increase the circulation and induce relaxation, thus enhancing the flow of 
nutrients, signal substances and oxygen to the tissues, simultaneously removing carbon 
dioxide and other waste products of cellular metabolism. Furthermore, when performing 
movements with awareness and attention, proprioceptive, kinaesthetic and interoceptive 
signals from the affected parts involved in the movement or posture reach the neural plexa, 
and signals are sent to adjust the movement or posture, and increase or decrease the muscular 
tone [106]. This interoceptive signalling helps the movements which are gentle, stimulating 
increased flexibility and muscle relaxation, which in turn enhances the blood circulation with 
the above-mentioned effects. Taken together, yoga seems to be an interesting treatment 
alternative, using other modalities than CBT, and thus may open up other possibilities for 
change. 
1.6 Mindfulness and mindfulness-based cognitive therapy (MBCT) 
Mindfulness-based cognitive therapy (MBCT) was developed from CBT to prevent 
depressive relapse [115]. The theoretical premise of MBCT is that depressive relapse is 
associated with lowered attention regulation together with other cognitive processes, 
especially rumination, i.e. repetitive, negative thinking and feeling that contribute to 
recurrence and relapse. MBCT targets cognitive reactivation [115]. The mindfulness 
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component also helps the patient to deal with experiential avoidance, i.e. avoiding painful 
feelings, thoughts and memories, and instead adopt an intentionally open, receptive and 
flexible attitude, being in the present moment. The evidence for effect as a relapse prevention 
is inconsistent, and seems to vary in different patient groups [116]. MBCT has shown an 
effect on active depression including treatment-resistant depression [117]. In this study 
MBCT was used as an additional new treatment. 
1.7 Rehabilitation and cognitive behavioural therapy (CBT) 
The recommended treatment in rehabilitation of patients diagnosed with CB is usually 
multimodal; using a bio-psychosocial model, i.e. psychological measures, usually CBT in 
groups or individually, and physical activity [43, 81]. Often, measures for improved sleep, 
coaching for return to work, stress management and body-awareness training are components 
of the treatment. The condition shows large individual differences and today individualized 
treatment is recommended in Sweden, for example by VISS, a medical and administrative 
support in primary health care [43]. Because no evidence-based treatments are available and, 
so far, only few studies have shown an effect from treatment on psychological complaints, 
the duration of sick leave and return to work [7], there is an urgent need for more studies on 
treatments. 
The usual length of treatment in CB studies is 8–16 weeks [10] and, generally, the 
participants have been on sick leave for a maximum of 6 months prior to inclusion [10]. 
Currently, we do not know the optimal length of treatment, and relapse is common [7]. Some 
also claim that treatment has no effect, only time can heal [7]. Treatment for CB is usually 
given at specialist clinics and in occupational medicine, while less severe cases of stress-
related illness are treated mostly in primary healthcare [43]. In previous studies CBT has 
shown an effect on depression, anxiety disorders, insomnia, symptoms of stress, and common 
mental disorders [118-120]. Psychological treatment has in a recent systematic review shown 
a small but significant decrease of sickness absence compared to care as usual [9], and CBT 
has shown an overall good effect on psychological complaints and HRQoL in patients with 
stress-related problems [121-123]. In a recent study, CBT + workplace intervention showed 
good effect on partial and full return to work [124].  
Randomized controlled studies that have been conducted in patients with CB, in this 
diagnosed (ICD-code F34.8A, ES) and well-defined population on sick leave, are scarce 
[118, 119, 122], and a few are found in similar groups by different names, in clinical studies 
and in mixed samples [124-127]. To find possible ways to diagnose CB, to find more 
effective prevention and treatment, and to decrease the incidence of relapse, a deeper 
understanding of burnout per se, and of efficacious treatment components is needed that 
includes the patient perspective. Methods that can be used in different healthcare settings are 
urgently needed. Prevention and early intervention are comparatively easy to implement, can 
be less complicated and may lower costs [8]. Both yoga and MBCT are methods that have 
recently been introduced in diverse medical health care settings. Both healthcare personnel 
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and patients have shown great interest in these types of methods and what they can 
contribute, even more so because evidence-based methods for CB are lacking. CBT is a well-
documented method and served as an active control group in the CBG. Group therapy could 
give lower therapy costs. Furthermore, participants can support each other, and group therapy 
may also increase the availability of therapy, as there is a lack of therapists. In addition, TY 
and MBCT can be practised at home and with occasional feedback delivered by a competent 
instructor under supervision. Furthermore, more available therapies will increase the 
opportunity to find suitable and individualized therapy, which is the recommended therapy in 
treatment guidelines in Sweden [43]. TY also give many health benefits besides stress 
reduction as the exercises encourage a healthy life style which CB patients warrant. 
In TY there are many exercises and components similar to the techniques used in cognitive 
therapy. Furthermore, TY considers mindfulness not as a method but a state of mind which 
the yoga practitioner tries to reach in exercise.   
2 AIMS AND HYPOTHESES  
2.1 Aims  
The overall aims of this thesis were to understand the situation of CB patients, to investigate 
the effect of traditional yoga on patients with CB on sick leave, and whether there are 
subjective and objective measures that can be used for screening and diagnose CB, to follow 
the course and evaluate treatment effects.  
Subjective measures 
To describe HRQoL in patients on sick leave with a diagnosis of CB, at baseline and in 
comparison with a HCG. 
To explore the effect of TY, MBCT and CBT on HRQoL in patients with CB. 
 Objective measures 
To evaluate potential biomarkers for screening, diagnosis, and for evaluation of treatment 
effects in patients with CB on sick leave. 
To compare the concentration of biomarkers at baseline with the concentration of biomarkers 
in HCG. 
To evaluate whether 1 µg ACTH test can be used as a stress test; to determine what would be 
the best time to sample cortisol after the injection in order to measure the maximum cortisol 
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That HRQoL in CBG would be low at baseline, and increase after psychological treatment 
with TY, MBCT and CBT.  
 
That a better effect could possibly be found with TY.  
Objective measures 
That the biomarkers at baseline would be below or above the reference range in the CBG, and 
would show significant differences compared to the HCG at baseline. 
 
That significant changes and trends would appear after treatment, with a potentially better 
effect with TY.  
 
That the1 µg ACTH test could be used as a stress test. 
 
 
In this thesis the results from the TY and CBT treatments will be discussed primarily, and 
MBCT to some extent.   
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2.3 Contents of thesis 
Figure 1 illustrates the content of the thesis based on two published articles and two 
manuscripts. 
2.3.1 Figure 1 Content of the thesis 
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3 RESEARCH METHODS AND MATERIALS   
3.1 Study population 1, the clinical burnout group (CBG) 
3.1.1 Study population and inclusion 
The patients were recruited chiefly from primary health care centres in Stockholm County 
Council, Sweden, as primary care is the health care setting where most CB patient primarily 
seek medical advice. The patient group came from a wide variety of occupations, mostly 
female white-collar workers. They were on sick leave, 50%, 75% or 100%, had a medically 
certified diagnosis by their family doctor and received sickness benefits, i.e. financial 
compensation. More than 90% of the patients had been on sick leave for a year or more. 
Altogether 702 patients applied to participate and were assessed for eligibility using an 
application form; subsequently, inclusion and exclusion criteria were confirmed over the 
phone (Table 2, for inclusion and exclusion criteria). In next step, 179 patients went through a 
psychological assessment to confirm the diagnosis of ES (Table 1) and psychiatric 
comorbidity. Finally, 119 patients were invited to participate (Figure 2, Flowchart). Of these 
94 patients, 84 women, and 12 men, agreed to participate and they were allotted by block 
randomization to the treatment groups, women and men separately. Fourteen patients 




























3.1.2 Study design  
 
  
Assessed for eligibility 
(n=702) 
Excluded (n=608) 
 Not meeting inclusion 
criteria (n=595) 
 Decline to participate 
(n=13) 




Allocated to TY (n=32) 
 Received allocated 
intervention (n=31) 
 Did not receive allocated 
intervention (n=1), feeling 
that too great a commitment 
was required (1)  
 
Allocated to CBT (n=31) 
 Received allocated 
intervention (n=30) 
 Did not receive allocated 
intervention (n=1) disliking 
group therapy (1) 
 
Allocated to MBCT (n= 31) 
 Received allocated 
intervention (n=30) 
 Did not receive allocated 
intervention (n=1) 
sickness (1)  
Follow-Up 
Discontinued intervention (n=5), 
due to personal reasons (1), 
moving away from the area (2), 
disliking group treatment (1) no 
longer being on sick leave (1) 
Lost to follow-up (n=0) 
Discontinued intervention 
(n=1) due to preferring some 
other group treatment (1)  
Lost to follow-up (n=2)  
sickness (1), and for personal 
reasons (1) 
Discontinued intervention 
(n=3) due to moving 
away from the area (1), 
and sickness (1) 
Lost to follow-up,( n=1), 
sickness (1)  
Analysis 
Analysed  (n=26) 
 Excluded from analysis (n=0) 
Analysed  (n=27) 
 Excluded from analysis (n=0) 
Analysed  (n=27) 
 Excluded from analysis (n=0) 
Enrolment 
  27 
 
Table 2 Inclusion and exclusion criteria  
Inclusion criteria 
Aged 18 to 65 years 
Being on at least 50% sick leave at the interview. Sick leave for a maximum of one year if on 
full-time sick leave at the interview, or for a maximum of three years if on part-time sick leave at 
the interview 
Body mass index (BMI) of between 18 and 26 
Meets the diagnostic criteria for Exhaustion Syndrome from the Swedish National Board of 
Health and Welfare, ICD 10 code; F43.8A  
Exclusion criteria 
Having other diseases that could give similar symptoms or hamper recovery 
Not speaking Swedish well enough and not being well enough to participate in the study 
interventions 
Using medication, including medicine containing glucocorticoids. Exceptions: antidepressants, 
sedatives, contraceptives and hormone replacement therapy. The patients were asked to take 
the same prescribed doses at both assessment times 
 
3.1.3 Interventions 
All three groups – TY, MBCT and CBT –received three hours of supervised group training 
per week. In addition, the participants practised on their own for 1–1½ hours, 3–4 times a 
week, including homework, for a total of at least 7 hours per week over five days. All 
participants followed this schedule, including the specific practices for each treatment arm 
stated below, for 20 weeks. All three groups practised various practical skills, such as 
formulating a self-motivated day-to-day activity chart and planning and executing a 
micropause as homework, see below, which was assessed during the following week’s group 
session. The activity chart was used to help the patients create a realistic planning system. 
They planned the following day’s activities the night before, and then during the day they 
endeavoured to follow their planned activities. In the evening they evaluated their work, 
rating how manageable their day had been and how they had felt emotionally during the day, 
thereby gradually coming to understand their limitations, i.e. validation [128]. During the 
micropause they tried for several minutes to be present with their bodily sensations and 
emotions while doing a brief practical task. This could, for example, be doing the dishes for a 
couple of minutes. The purpose of the micropause is to help the patients get closer to 
themselves with a deeper understanding of how they feel and how things affect them. The 
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groups consisted of 9–11 participants and three series of groups went through the programme. 
The instructor for all of the TY groups was a physician (AG), a trained TY teacher with many 
years of personal practice and of teaching TY. In the CBT groups, a licensed psychotherapist 
with extensive clinical experience in the field conducted the treatment. All three treatments 
were designed by the psychotherapist (BA), who is also a traditionally educated yoga teacher. 
The treatments were designed to suit the needs of the patients, expressed during the personal 
interviews. 
Traditional yoga  
The participants in this arm practised TY, a variation of Ashtanga yoga, which is a form of 
yoga with gentle movements and postures (asanas), breathing exercises and meditation (Table 
3). The TY which was used in this study is mild and does not demand too much effort, 
considering the physical and mental state of the patients. The programme was designed 
specifically for this group of patients. Because they did not have much previous yoga 
experience, and to take into account their mental and physical state, the programme was 
introduced in two steps (Table 3). The overall purpose of the TY intervention was to help 
participants attain increased awareness of their own bodily sensations and emotional feelings. 
The main components of TY were 
1. Physical movements and postures (asanas); about 70%. 
2. Breathing exercises; active and passive, about 20%. 
3. Awareness: During all exercises, focus on feelings and bodily sensation was encouraged in 
order to understand and experience what was going on physiologically and emotionally. 
4. Processing feelings by exercising the previous three components, so the individual 
gradually comes in contact with and becomes more aware of his or her feelings and emotions 
[33], and learns how to be present with and to experience difficult feelings and emotions 
instead of avoiding them. 
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Mindfulness-based cognitive therapy 
The MBCT intervention was designed with the aim of teaching mindfulness and cognitive 
skills as a means to note distressing thoughts and feelings. They include: being aware of and 
recognizing one’s own bodily sensations, attending to distressing thoughts and feelings by 
holding them in the present, and cultivating acceptance and self-awareness. These exercises 
possibly contributed to an awareness of a present-moment experience concomitantly with a 
compassionate, non-judgmental state. Additional skills, such as how to plan a satisfactory day 
by their own definition (using a self-motivated day-to-day activity chart), how to plan and 
execute micro-pauses, and how to accept negative feelings without being overwhelmed by 
them, were also on the agenda. Participants were taught to focus more on the emotional part 
of their feelings and less on their thoughts when they were practising mindfulness. 
Homework consisted of a protocol for measuring/observing negative feelings, body-mind 
awareness exercises, a day-to-day motivated chart, and instructions to follow a special theme 
for the week. All assignments and homework were assessed and analysed during the 
following week’s group session. 
Exercises [82, 129] 





Padahastasana (Standing forward bend) X X 
Supta pawanmuktasana (Knee-lock pose) X X 
Bhujangasana (Cobra pose) X X 
Ardha Salambhasana (Half grasshopper pose) X X 
Digapranam (Salutation) X X 
Vajrasana (Diamond pose) X  
Breathing exercise X X 
Vipareet Karan Mudra (Inverted pose)  X 
Matsyasana (Fish)  X 
Yoga Mudra (Sitting, forward bend)  X 
Tadasana (Mountain pose)  X 
Kapal Bati (Bellow breathing)  X 
Chakki Chalanasana (Grind grain)  X 
Meditation X X 
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Cognitive behavioural therapy 
In addition to the day-to-day activity chart and the micropause, the CBT programme was 
comprised of various working components such as cognitive restructuring, applied relaxation 
technique, identifying stressors, coping with stress, and how to reduce the experience of daily 
stress. The homework included a protocol for negative thoughts, relaxation, and a special 
theme for the week. Each session had a specific theme, based on different cognitive and 
behavioural concepts and the theory behind the practical exercises, as well as working 
material and the specific homework assignment. Reports on the daily working chart were 
used for self-monitoring of day-to-day behaviour and reactions. The structure of a therapeutic 
session included formulating a jointly agreed work agenda for the group, a brief period of 
relaxation, reflections on the previous session, follow-up of the homework assignment, 
introduction of new themes, and preparation for the next homework assignment.  
3.2 Study population 2, the HCG 
3.2.1 Study population and inclusion 
A group of 88 healthy participants (72 women and 16 men) who were working full-time and 
experiencing stress at work, but who did not fulfil the criteria for exhaustion syndrome, were 
used as the comparison group (HCG). They were chosen for the purposes of comparison, 
because the majority of the CBG had quite recently been in a situation similar to that of the 
HCG – working full-time and experiencing stress at work – and thus they were considered a 
suitable group for comparison. They were drawn from a previous study on stress 
management for health care personnel, and were recruited from May 2003 until December 
2005 via self-referral from nine health care units in the Stockholm metropolitan area. The 
inclusion criteria for the HCG were the same as for the CBG, regarding age and weight. In 
addition, they were subjectively healthy, had no known diseases, and they were taking no 
medication, including hormonal contraceptives. None had endogenously elevated TSH and 
cortisol levels or had used exogenous glucocorticoids in any form during the last three 
months prior to the blood sampling and ACTH stimulation test. All women were 
premenopausal.  
3.2.2 Measurements  
The measurements were subjective and objective. Data were sampled at baseline for SWED-
QUAL (I + II), and for biomarkers (III) in both the CBG and HCG. In the CBG, data were 
also collected after treatment (II + III). Data from the 1 µg ACTH stimulation test were 
derived from samples taken at baseline and after treatment in the HCG (IV). Blood sampling 
and the ACTH stimulation test were made in the follicular phase of the menstrual cycle.  
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3.2.2.1 Subjective measures – HRQoL (I +II) 
As patient-reported HRQoL is a primary goal in today’s healthcare, most studies explore 
some type of patient-reported outcome. In both our studies reflecting HRQoL, the Swedish 
health-related quality of life questionnaire, 1.0 (SWED-QUAL, Table 4) was used as primary 
outcome variable, employing the full version of this generic instrument [79]. SWED-QUAL 
is derived from the Medical Outcome Study (MOS) and SWED-QUAL is similar to SF-36 
[130], although SWED-QUAL is based on subscales instead of a single global measure, 
which facilitates interpretation of the results. Furthermore, SWED-QUAL is a well-validated 
instrument in the Swedish general population. Moreover, SWED-QUAL is more extensive 
than SF-36, with several questions on social, cognitive and sexual functioning – aspects of 
life which are often affected in patients with burnout [131]. SWED-QUAL has been used in a 
wide range of studies on somatic as well as psychiatric conditions [78, 132]. It comprises 67 
self-assessed questions on the present situation (now or the past week) grouped into 13 
subscales, each with a separate index, from 0 (worst) to 100 (best possible). The subscales 
and descriptions are listed in Table 4. The questions are formulated negatively or positively, 
with four alternative answers such as No, not at all = 1, Yes, slightly = 2, Yes, fairly much = 
3 or Yes, very much = 4. For some of the questions a Likert scale format is used with answers 
ranging from completely agree = 4 to completely disagree = 1. In addition, six questions on 
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Table 4 Characteristics of subscales in SWED-QUAL  
Subscale  Number 
of items  
Description 
Physical functioning 7 Extent to which health interferes with ability to perform physical activities (e.g., heavy manual work, sports, climbing 
stairs, dressing) 
Satisfaction with physical functioning  
1 Satisfaction with physical ability to do as wanted 
Pain, frequency and intensity  6 Pain frequency, intensity and interference with activities of daily life (ADL), sleep and mood 
Role limitation due to physical health  3 Extent to which physical problems interfere with ADL 
Role limitation due to emotional health  3 Extent to which emotional problems interfere with ADL 
Positive affect 6 Is a happy person, feels liked, emotionally in harmony, much to look forward to 
Negative affect  6 Feels nervous, tense, down, sad, impatient, annoyed  
Cognitive function  6 Concentration, memory, capacity to take decisions, confusion 
Sleep quality  7 Problems with sleep initiation and maintenance, sleep adequacy and somnolence 
General health perceptions 8 Health: prior and current, overall rating of health, immune defence, health worries 
Satisfaction with family functioning 4 Satisfaction with family life in terms of cohesiveness, amount of support and understanding, amount of talking things 
over, overall happiness with family life 
Satisfaction with partner functioning  6 Relation to spouse (or person felt closest to) in terms of saying anything wanted, sharing feelings, feeling close, 
being supportive 




3.2.2.2 Objective measures – biomarkers (III) 
The objective outcome variables were 23 and 20 biomarkers for the CBG and the HCG, 
respectively. The biomarkers in blood and urine were selected from markers that have 
previously been used in stress research, in research on psychological treatments, or after yoga 
treatment. They were measured before and after five months of treatment with TY, MBCT or 
CBT. Adrenocorticotropic hormone (ACTH), prolactin, cortisol, dehydroepiandrosterone 
sulphate (DHEAS) testosterone, estradiol sensitive (estradiol), sex hormone binding globulin 
(SHBG), C-reactive protein, sensitive (CRP), thyrotropin (TSH), thyroxine (T4), 
triiodothyronine (T3), fasting plasma glucose (glucose), glycated haemoglobin (HbA1c), 
fasting plasma cholesterol (cholesterol), fasting plasma high-density lipoprotein (HDL), 
fasting plasma triglycerides (TG), urinary 5-hydroxyindoleacetic acid (u-5HIAA), urinary 
epinephrine (u-epinephrine), urinary norepinephrine (u-norepinephrine), urinary dopamine 
(u-dopamine) and urinary cortisol (u-cortisol) were analysed. Low-density lipoprotein (LDL) 
was calculated from total cholesterol, and the cholesterol ratio LDL/HDL was obtained.  
3.2.2.3 Objective measures – ACTH stimulation test (IV)  
The 1 µg ACTH stimulation test was performed in the morning, and the participants were 
instructed to fast starting at midnight and to refrain from alcohol, nicotine and caffeine-
containing beverages. They were also asked to refrain from exertion leading to 
breathlessness 12 h prior to the test. Adherence to these guidelines was confirmed before 
the test. An intravenous cannula was inserted in an antecubital vein and kept patent with 
saline. The participants then rested for 30 min. ACTH (Synacthen®, Novartis Healthcare 
A/S, Copenhagen, Denmark, in the amount of 0.25 mg/ml) was freshly diluted to 1 µg/ml 
prior to use. After the 30 min rest period, baseline saliva and blood samples were collected 
(0 min). Immediately following collection of the blood sample at baseline (0 min), 1 µg 
ACTH was administered i.v. for one min, beginning no later than 0815 h. Saliva and blood 
samples were collected simultaneously at 20, 30, 40, 50 and 60 min following ACTH 
stimulation. 
3.3 Statistics  
3.3.1 Sample size CBG (II + III)  
The sample size needed was estimated to be approximately 20–25 participants per group. The 
calculation was based on estimation, as when the study was designed there were no relevant 
studies in this field, and power analysis to determine the (effective) sample size was not 
possible. In a population (a cohort study) with diabetes type I and II  the sample size was 40 
persons per group with a power of 80% and α = 0.05 based on a difference of 8 points on 
the SWED-QUAL subscale “general health perceptions”, which is often used for comparison 
between groups and for sample size calculations [132]. Since the participants in our study had 
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a condition that was far worse than in the diabetic group, we assumed that the sample size 
could be smaller.  
3.3.2 Sample size HCG (I + III + IV) 
The sample size for a comparison between a group of people experiencing emotional ill 
health who were attending a mind-body medicine course and people in the general 
population was previously calculated to be 88 persons per group [133]. The calculations 
were based on an estimated difference of 7.5-scale points in the subscale general health in 
SWED-QUAL. In this study, the expected difference between the groups was larger. Thus, 
the number of persons needed per group could be smaller.  
3.3.3 Statistics in each article 
Article I: A Bonett-Price 95% confidence interval (CI) and median were calculated [134]. 
Also, Bonett-Price calculation for differences in medians was used to compare the subscale 
scores of the CBG with the subscale scores of the HCG to establish whether there were 
significant differences in scores. The significance level chosen was <0.05. Due to multiple 
comparisons, the Holm-Bonferroni correction was used in the statistical calculations for the 
outcome variables [135]. Effect size was calculated using Cohen’s D, and in study I effect 
size was used to measure the relative difference in subscale scores between the CBG and 
the HCG. Effect size is the ratio of the mean difference in scores from the weighted SD and 
indicates whether a difference in subscale scores is clinically relevant or not. Cohen’s D 
<0.2 is considered without importance, 0.2−<0.5 is a small difference, 0.5−<0.8 is a 
moderate difference, and ≥0.8 is a large difference. When Cohen’s D is 1.0, the mean effect 
corresponds to the SD. 
 
Missing data were found almost exclusively in items concerning “satisfaction with partner 
functioning” and “sexual functioning”, and the proportions of persons not answering these 
items were 14 and 8%, respectively, in the HCG, and 14% for both items in the CBG, 
findings similar to those in previous studies [136].  
 
Article II Wilcoxon’s rank sum test [137] was used for comparison of the treatment groups’ 
subscale scores at baseline and for comparison of the between-group treatment effect. 
Wilcoxon’s sign rank was used for comparison of treatment effects [137]. Effect size was 
calculated using Cohen’s D [138]. The median and the confidence interval were determined 
using the Bonett-Price calculation [134]. The significance level was set at < 0.05. Because 
there were multiple comparisons, the Holm-Bonferroni correction was used in the statistical 
calculations for the outcome variables [135].  
 
Missing data were found, with few exceptions, in the subscales sexual function and partner 
functioning. This is in accordance with previous studies [136]. Those who did not answer 
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these items lived almost exclusively alone and had reported that they did not have a partner. 
The analyses were carried out according to the protocol.  
 
Article III: The median and the confidence interval for the concentrations pre- and post-
treatment were determined using the Bonett-Price calculation [134]. Student’s T-test and 
Bonett-Price calculations were used for calculation of treatment effects within the groups 
and for all groups together as well as for comparison of the treatment effects between the 
groups and for the comparison between the healthy group and the treatment groups, all 
together [134, 139]. Student’s T-test was used for normally distributed differences of 
concentration post- and pre-treatment, and Bonett-Price calculation was used for 
biomarkers with skewed distributed differences of concentration post- and pre-treatment   
[134, 139]. As this is a hypothesis-generating study the significance was set at two different 
levels: P <0.05 and for trend P ≥ 0.05–0.20. Also, for the same reason, no correction for 
multiple comparisons was made in the statistical calculations for the outcome variables.  
 
Article IV: To determine the best time to measure the maximum response value, the number 
of maximum response values was calculated for each measure time; 20, 30, 40, 50 and 60 
min after stimulation. The measure time with the most maximum response values was 
considered to be the best time to measure. Furthermore, the maxima at 30 or 40 min that were 
close to the maximum response value were considered to be the maximum response when 
calculating the number of maximum responses at each measure time. The median of the 
maximum concentration values at 20, 30, 40, 50 or 60 min was also compared to the median 
of the maximum concentration values at the time found to be the best time to measure, using 
the Fisher-Pitman permutation test, (P < 0.05) [140]. To compare the secretion of cortisol in 
serum and saliva, generalized estimating equation (GEE) was used to establish whether or not 
salivary and serum cortisol concentration curves were parallel [141]. GEE takes into account 
unequal variance and unstructured correlation, as was the case with the data used for GEE 
calculations in this study. We assumed unstructured correlation between measurements over 
time for each participant, and the calculation was made using the Huber-White sandwich 
estimator of variance (P > 0.05) [142].  
 
Data analyses were conducted using the statistical program STATA versions 10.1, 11, 11.2 
and 13 for Windows, StataCorp. (2009). Stata Statistical Software [143]. 
3.3.4 Statistical considerations  
Subjective measures: (I + II) As the data are ordinal, the group-wise and between-group 
analyses of scores were done using non-parametric methods. To enable comparison with 
previous studies, percent increase and Cohen’s D were calculated. An analysis using 
parametric methods was also carried out, and it yielded the same results for P-values. The 
results pre- and post-treatment differed slightly when presented as means instead of medians, 
but the general trend remained. Another phenomenon, “regression towards the mean”, might 
have influenced the scores. For example, if SWED-QUAL is completed on a second occasion 
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in close proximity to the first, the scores tend to be closer to the mean. This could have 
influenced the scores to some extent in our group, but it is unlikely to have changed the 
results. 
Objective measures: ( III) Missing data were found mostly due to missing blood tests, non-
adherence to the sampling instructions or problems at the laboratory when analysing. One 
participant fulfilled the diagnostic criteria for diabetes and the blood tests for fP-glucose 
and HbA1c were excluded from the analysis for that patient. The analyses of estradiol and 
DHEAS were made in premenopausal women without contraceptives and hormone 
replacement therapy only, and during the follicular phase of the menstrual cycle. The 
analysis of testosterone was made in all women, pre- as well as postmenopausal. The 
results for testosterone were reported as this is the most common to report, and as the 
results for testosterone and for bioactive testosterone were similar. The analyses were 
carried out per protocol. No serious adverse events occurred in the treatment groups.  
3.3.5 Ethical considerations 
The regional Ethical Review Board in Huddinge, Stockholm, Sweden, approved the studies 
included in this thesis. The studies were conducted in accordance with the 1964 Helsinki 
declaration and its later amendments or comparable ethical standards.  
All participants in both studies gave their informed written consent to participate. 
When designing the study for the CBG, three different arms were chosen. Two new 
treatments with additional features were compared to CBT, which is the most common type 
of psychological support used as treatment for CB. In this study CBT was used as the active 
control group. No inactive control group was employed, as the longer you are on sick leave 
the more difficult it becomes to return to work. Also, recent data indicate that there might be 
a deterioration of the condition in an inactive control group [144]. 
The instructions for blood sampling and collection of urine might be complicated to 
understand and to follow for certain persons. This is true especially for patients with CB who 
often have cognitive impairments. Much emphasis was laid on encouraging an open and 
tolerant atmosphere for patients in order to make them feel free to phone for practical support 
and repeated instructions if necessary. Furthermore, they could call as many times as needed 
for a correct sampling, primarily of urinary collection. Blood sampling in both studies was 
conducted at laboratory by trained personnel in accordance with usual routines, and so was 
the ACTH test in study population 2, the HCG.  
In the CBG a telephone interview was conducted with the persons who met the inclusion 
criteria in the application form, to confirm that the information was correct. That was done to 
minimize the number of persons who were denied inclusion after the personal interview, as 
we found that in many cases a denial was a great disappointment to the applicant, and often 
was perceived as personal failure. An explanation of why they were not considered for 
inclusion, and what they could do instead, was given to those applicants.  
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When filling in the questionnaires all the participants, both in the HCG and patients in the 
CBG, could do it at home, and at their own pace. They were encouraged to take their time 
and do it in several sessions if needed, to avoid answering mechanically. In the CB study the 
patients filled in the application form and questionnaires directly into the database. For the 
questionnaires, they used a personal code. In HCG the participants filled in questionnaires on 
paper. 
Data in paper format (HCG study) (application forms, questionnaires and lab data) were 
anonymized and coded. All were kept in a locked storage during the active phase of the 
study. All were later on destroyed. Lab data, filled-in questionnaires and code keys for the 
HCG study were transferred into digital data files, stored at the department in encrypted areas 
on the disk. In the CB study only AG had access to these data. Data were presented at group 
level, to eliminate the risk that individual data would be identified. As few men participated 
and the spread in age was considerable, making it possible to identify individuals, individual 
data have not been transferred to public repositories, in order to protect their anonymity.  
4 MAIN RESULTS 
4.1 Sociodemographic data 
Study populations 1 and 2: the CBG and the HCG (I–IV) 
The CBG consisted mainly of middle-aged women with a high education (Table 5). Most of 
them had a partner and more than half of them were prescribed psychotropic drugs (anti-
depressants, sleep-medication and tranquillizers), which at that time, was 5 times higher than 
in the general population (Table 5). Approximately 20% of these did not use their prescribed 
medicine, chiefly due to worry about side effects, no effect or a wish to handle the situation 
without medication. The majority were on full-time sick leave (Figure 3). A total of 92% of 
the patients had been on sick leave for 1 year or more at the start of the intervention. Of the 
patients in the CBG, 80% reported that they were sick because of work-related causes (Figure 
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Figure 3 Sick leave   Figure 4 Reason for being sick 
Figure 5 Occupation   
 
All participants fulfilled the diagnostic criteria for ICD-10 code F43.8A (ES) and also the 
criteria for depression and anxiety. In the HCG the majority were women (Table 5). They 
reported that they were healthy but experienced stress, had no known diagnoses, and all were 
pre-menopausal, without medication or contraceptives. The CBG and the HCG were equal at 
baseline regarding sociodemographic variables. Both groups had higher education than the 
general population (Table 5). Fourteen patients withdrew from the CBG. The scores and 
sociodemographic variables of these patients were equal to the scores of the CBG patients 
who continued in the study.  
Most of those who were not admitted to the study did not fulfil the inclusion/exclusion 
criteria, while the patients that declined to participate did so mostly as they felt that the study 



































Table 5 Sociodemographic data and medication for the clinical burnout group (CBG) 
compared to the healthy comparison group (HCG) and the Swedish population, women only. 
 CBG HCG Swedish populationa 
    





Age, years, mean ± SEM 43.7 ± 0.97 40.0 ± 1.1 39–45 
Education, years, %  
   
≤ 9 years 2 3 7 
> 9–12 years 
 
24 24 49 
> 12 years 
 
74 73 44 
Having a partner, % 
 
61 69  
Medicationb, psychotropic drugs prescribed, % 
Antidepressants, ATC NO6 
Sleep medication and tranquilizers, ATC NO5 








aThe official Swedish population statistics in 2003–2008 from the National Board of Health and Welfare, and the 
National Social Insurance Board and Statistics Sweden are included for comparison in this table. b ATC code 
NO6, antidepressants; ATC code N05, sleep medication and tranquillizers and ATC code NO2, painkillers. 
 
4.2 Subjective measures, HRQoL measured by SWED-QUAL 
4.2.1  Article I, descriptive and comparative results 
In today’s healthcare, HRQoL is an important marker for the patients’ perspective. It is 
known to predict future health, sick leave and mortality, and is the primary outcome variable 
in this thesis. At baseline, the CBG had low scores in 12 out of 13 subscales, with median 
scores ranging from 22–58 points (100 points=best possible health). These low scores were 
equal to or even lower than SWED-QUAL scores previously found in patients with severe 
psychiatric illness or chronic somatic diseases [78, 145]. The last subscale, “physical 
functioning”, had a close to normal median score of 86 points. When the baseline scores were 
compared to the scores of the HCG, the scores were significantly lower in the CBG, p < 
0.001, in all subscales, including physical function. A median difference of 24–56 points 
was found for the subscales except for the subscale “physical functioning”; here the 
significant difference was only 10 points due to the above-mentioned higher baseline score. 
The largest median differences were found in subscales associated with the criteria for the 
diagnosis of ES, for example “role limitation due to emotional health”, and “role limitation 
due to physical health” which measure the impairment in role functions, such as being a 
partner, parent or employee, because of decreased emotional and physical health (Table 6). 
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Furthermore, the subscales “positive affect”, “negative affect”, “general health”, “cognitive 
function” and “sexual functioning” were affected to a high degree. The two subscales that 
deal with social function – “satisfaction with family functioning” and “satisfaction with 
partner functioning” –were decreased to a lesser degree, indicating that many in the CBG felt 
that they had fairly good social support. Interestingly, considering that the subscale “physical 
health” was the subscale that showed the least decrease, “satisfaction with physical health” 
was low. The spread of the scores is indicated by the confidence intervals (CI) (Table 6). 
When comparing the CI of two groups, the results become more reliable if the CI’s are 
similar, as is the case in this study. Furthermore, the effect sizes were high, ranging from 
0.85–2.01, and showed large differences between the two groups. Taking into account both 
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Table 6 SWED-QUAL scores in the clinical burnout group (CBG), in the healthy control group (HCG), and the median difference between the 






Median (95% CI), n = 94 a 
HCG  
 
Median (95% CI), n = 88 
Difference b CBG vs HCG 
 
Median (95% CI) 
Test of difference 
 
Effect size, Cohen’s D c 
Physical functioning 86 (81–90) 95  (93–99) 10 (4–15) 1.19 
Satisfaction with physical functioning 33 (33–33) 67   (67–67) 34 (34–34) 1.17 
Pain 58 (50–65) 85   (82–87) 27 (19–35) 1.15 
Role limitation due to physical health 33 (27–39) 89   (78–100) 56 (44–68) 1.73 
Role limitation due to emotional health 22 (11–33) 78   (67–89) 56 (41–71) 1.98 
Positive affect 40 (31–48) 75   (67–83) 35  (24–47) 1.48 
Negative affect 25 (19–31) 67   (61–73) 42 (33–50) 1.73 
Cognitive function 25 (21–29) 79   (75–83) 54 (48–60) 2.01 
Sleep 41 (34–48) 75   (68–82) 34 (24–48) 1.23 
General health 44 (39–48) 91   (88–94) 47 (41–52) 2.01 
Satisfaction with family functioning 50 (38–62) 79   (75–83) 29 (16–42) 0.89 
Satisfaction with partner functioning 58 (52–65) 82   (80–84) 24 (17–30) 0.85 
Sexual functioning 40 (33–47) 95   (88–102) 55 (45–65) 1.22 
a = two persons with missing data. b Calculated by Bonett-Price. c =The effect size is the difference in scores between the healthy group and the study group divided by the pooled  
Standard Deviation (SD). An effect size > 0.8 is considered a large difference between the groups. c = Wilcoxon sign-rank test.  
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4.2.2 Article II, HRQoL in all and in each treatment group at baseline and 
after treatment 
The next step was to calculate the median baseline scores with CI in all groups calculated 
together and in each treatment group, TY, MBCT and CBT. Furthermore, to calculate the 
difference between pre- and post-treatment scores. The results are shown in Figure 4 and 
Table 7. The results from all three groups showed that the HRQoL significantly improved 
after treatment. In TY 26 patients (5 men), and in both MBCT and CBT 27 patients in each 
(3 and 2 men respectively) were analysed. Ten subscales in TY and seven subscales in 
MBCT and CBT showed improvements, p < 0.05. The increases were especially found in 
the main domains covering aspects known to be affected in burnout, e.g. emotional as well 
as physical well-being, cognitive function and sleep. When calculating the median 
differences in scores post- and pre-treatment, they were found to be large in general. In TY 
the increase was from 0–27 points and in CBT from 4–25, and from 0–25 in MBCT. The 
ES was mainly medium or large. TY and MBCT showed a slightly better effect size than did 
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Figure 6 Test of treatment effect (post-pre) a in SWED-QUALb median, subscales scores, 
ranging from 0 (worst) to 100 (best) possible, after 20 weeks’ treatment with Traditional 
Yoga (TY), Cognitive Behavioural Therapy (CBT) (control) or Mindfulness-based Cognitive 
Therapy (MBCT). Significant p-values, P < 0.05, and after Holm-Bonferroni correction are 
indicated by (*). 
 
a Wilcoxon’s sign-rank test was used for comparisons in each group. 




























































Table 7 SWED-QUAL baseline median subscale scores ranging from 0 (worst) to 100 (best possible)a, and test of treatment effectb per group and for all. 
Main results markedc.    







P-value ES Baseline 
(CI) 





Physical well-being             
  Physical functioning 86 (83-88) 0.0003 0.36 86 (81-90) 0.0207 0.34 90 (86-95) 0.4908 0.16 81 (74-88) 0.0009 0.51 
  Satisfaction with physical functioning 33 (33-33) 0.0000 0.49 33 (33-33) 0.0031 0.52 33 (16-50) 0.0185 0.55 33 (16-50) 0.0426 0.39 
  Pain 53 (45-61) 0.0027 0.30 50 (38-62) 0.0987 0.29 62 (49-76) 0.1631 0.14 33 (16-50) 0.0122 0.55 
  Role limitation due to physical health 33 (33-33) 0.0000 0.59 33 (18-48) 0.0105 0.54 33 (27-39) 0.0043 0.65 53 (42-63) 0.0362 0.45 
Emotional well-being              
  Role limit. due to emotional health 22 (11-33) 0.0000 0.91 11 (3-26) 0.0006 0.93 33 (22-44) 0.0036 0.82 33 (22-44) 0.0004 0.99 
  Positive affect 38 (31-44) 0.0000 1.03 40 (25-56) 0.0009 1.05 33 (17-50) 0.0005 1.12 42 (31-52) 0.0011 0.90 
  Negative affect 25 (19-31) 0.0000 0.96 33 (22-45) 0.0000 1.0 29 (21-38) 0.0002 0.81 21 (17-25) 0.0001 1.07 
             
Cognitive function 25 (21-29) 0.0000 0.91 29 (14-44) 0.0001 0.73 25 (17-33) 0.0001 0.9 13 (2-23) 0.0000 0.91 
Sleep 41 (36-47) 0.0000 0.79 36 (24-47) 0.0008 0.69 43 (34-52) 0.0010 0.73 46 (37-55) 0.0002 0.97 
General health 50  (44-56) 0.0001 0.47 44 (37-51) 0.0041 0.59 50 (36-64) 0.0303 0.45 53 (34-72) 0.0658 0.34 
Satisfaction with family functioning 46 (33-58) 0.0000 0.60 38 (15-60) 0.0010 0.52 40 (23-56) 0.2112 0.32 55 (35-75) 0.0097 0.46 
Satisfaction with partner functioning 60 (54-66) 0.0041 0.31 58 (42-75) 0.0443 0.21 58 (47-70) 0.0048 0.18 67 (49-84) 0.4155 0.20 
Sexual functioning 45 (40-50) 0.0000 0.58 45 (30-60) 0.0019 0.5 48 (29-66) 0.2119 0.25 40 (33-47) 0.0009 0.62 
a Bonett-Price confidence interval (CI). bWilcoxon sign-rank test and effect size (ES). Effect size, Cohen’s D< 0.2 is considered as no effect, ≥ 0.2 < 0.5 a small effect, ≥ 0.5 < 0.8= a 
medium effect and ≥ 0.8= a large effect. c Significant ES and p-values after Holm-Bonferroni correction in bold and in marked areas. 
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4.2.3 Comparison of the treatments 
The effect of the treatments was compared and a better effect from TY was found in 
altogether seven of the subscales, 5 when compared to CBT, and two when compared to 
MBCT, Cohen’s D of 0.22–0.43 (Table 8). This might indicate a slightly better effect from 
TY than from CBT and MBCT in certain domains. TY had a larger increase in “negative 
affect” compared to CBT, p = 0.09 which probably in turn helped to increase “role 
limitation due to emotional health” more in TY compared to CBT, p = 0.25. MBCT had a 
better effect size than TY in two subscales (Table 8). 
 
Satisfaction with the treatment: All patients reported that they were satisfied with the 
treatment and experienced a good effect.  
 
Attendance: The yoga teacher and the psychotherapist recorded the attendance. Also, the 
patients in CBG executed the activity chart every day, and reported the exercises they had 
performed. Then they turned in their homework and activity chart to the psychotherapist or 
yoga teacher each week. The attendance for the groups was similar, with no significant 
difference, TY mean 69%, MBCT mean 75%, and CBT mean 70%.  
 
Adherence: All three groups reported similar time spent on homework; in the TY mean 
89.4 h, in the MBCT group 90.4 h, and 83 h in the CBT group.  
 
Adverse events: At each session the patients were requested to report and discuss problems 
and adverse events, and if any, notes were taken. Moreover, the patients were asked to 
contact the therapist/yoga teacher if they had any concerns concerning the treatment. No 






















Table 8 Comparison between the groups’ treatment effects, measured by SWED-QUAL 
subscale scores, as p-valuesa and effect sizeb. 
Subscale TY – CBT MBCT – CBT TY – MBCT 
 P-value ES P-value ES P-value ES 
Physical functioning 0.28 0.09 0.13 0.44 M 0.70 0.29 M 
Satisfaction with physical functioning 0.82 0.06 0.89 -0.08 0.71 0.06 
Pain 0.39 0.18 0.38 -0.07 0.66 0.13 
Role limitation due to physical health 0.76 –0.02 0.47 0.33 M 0.75 0.04 
Role limitation due to emotional health 0.25 0.39 Y 0.36 0.32 M 0.95 0.1 
Positive affect 0.94 0.07 0.52 -0.17 0.70 0.23 Y 
Negative affect 0.09 0.43 Y 0.19 0.37 M 0.65 0.09 
Cognitive function 1.0 0.01 0.38 0.32 M 0.35 0.28 M 
Sleep 0.40 0.16 0.16 0.36 M 0.66 0.16 
General health 0.41 0.26 Y 0.88 0.04 0.69 0.20 Y 
Satisfaction with family functioning 0.14 0.22 Y 0.32 0.15 0.46 0.07 
Satisfaction with partner functioning 0.60 0.05 0.47 0.01 0.87 0.04 
Sexual functioning 0.39 0.31 Y 0.48 0.30 M 0.91 0.09 
a Wilcoxon rank-sum test. bEffect size (ES), Cohen’s D< 0.2 is considered as no effect, ≥ 0.2 < 0.5 a small effect, 
≥ 0.5 < 0.8= a medium effect and ≥ 0.8= a large effect. Significant ES and p-values after Holm-Bonferroni 
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4.3 Objective measures, Biomarkers and ACTH test 
4.3.1 Article III, Biomarkers 
The concentration of biomarkers at baseline in all treatments was calculated together and in 
each treatment group. Comparisons with the HCG, and with concentrations after treatment, 
were made in each treatment group at baseline and after treatment (III). 
Before treatment, all biomarkers were within normal range in the CBG, both when all groups’ 
concentrations were calculated all together and when each group’s concentrations were 
calculated. When the results were compared to those of the HCG, urinary 5-HIAA, 
dopamine, epinephrine and nor-epinephrine showed significantly higher concentration, 
together with HbA1c, while urinary cortisol showed a significantly lower concentration 
(Table 9). 
 
Table 9 Test of difference in concentration between CBG and  
HCG. Presented as p-value (P) and median for the numerical  
difference with 95% confidence interval (CI). The biomarkers  














a Glycated haemoglobin (HbA1c), high-density lipoprotein (HDL).  
b Bonett-Price was used to calculate the difference in median for  
the groups. Significant (<0.05) p-values in bold underlined and  





Biomarkera CBG, n=71–79 – HCG, n=21 
 P Diff 
Cortisol (nmol/L)  0.071 71 (–6.11; 148.1) 
Glucose (mmol/L)  0.15 –0.21 (–0.49; 0.074) 
HbA1c (mmol/mol) <0.001 –4 (–5.84; –2.16) 
HDL (mmol/L) 0.068 0.2 (–0.015; 0.41) 
U-5HIAA (µmol/d) < 0.001 12.5 (7.47; 17.52)e 
U-dopamine (nmol/d) <0.001 520 (226.8; 813.20) 
U-epinephrine (nmol/d) 0.004 10 (3.10; 16.90) 
U-norepinephrine (nmol/d) <0.001 92 (42.8; 141.18) 
U-cortisol (nmol/d) <0.001 –78.90 (–105.26; –52.54) 
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The effect of psychological treatment  
After treatment the concentrations of all biomarkers were stable and within the reference 
interval. The within-group effect of the treatments is shown, in all analysed together (study 
group) (n=71–79), and for each treatment group, TY, MBCT and CBT (Table 10).  
When all the patients’ concentrations were analysed together a significant change was seen in 
testosterone and urinary epinephrine (decrease) and in estradiol and glucose (increase). When 
the treatment groups were analysed separately, testosterone showed a significant decrease 
with CBT and MBCT, and a trend to decrease with TY. CBT showed a significant increase in 
estradiol and MBCT showed a significant decrease in dehydroepiandrosterone-sulphate 
(Table 10).  
Treatment effects; calculated in the study group, n=71–79 
A significant change in concentration (treatment effect), P< 0.05, was seen in four of the 
biomarkers (Table 10, column 1), with an increase in estradiol and a decrease in testosterone 
and in u-epinephrine (Table 2).  
Results in each treatment group  
Treatment effects of traditional yoga (TY), n=24–26 
In the TY group no significant changes were found after treatment in any one of the 23 
biomarkers (Table 2). A trend for an effect was seen in four biomarkers; a decrease in 
testosterone, LDL/HDL ratio and u-epinephrine (Table 2).  
Treatment effects of Mindfulness-based Cognitive Therapy (MBCT), n=23–27 
In MBCT, as in all analysed together, four biomarkers showed an effect. A decrease was 
found in DHEAS, testosterone and u-epinephrine (Table 10). 
Treatment effects of Cognitive Behavioural Therapy (CBT), n=23–26 
In CBT, three significant changes and three trends were found, with a decrease in cortisol and 
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Table 10 Test of treatment effect (post – pre) in the study group (ALL), and in each group of treatment; traditional yoga (TY), mindfulness-based cognitive therapy 
(MBCT) and cognitive behavioural therapy (CBT). The biomarkers that showed an effect or a trend are presented here as p-value (P) and mean or median (e) for the 
numerical difference, with 95% confidence interval (CI).  
a Concentrations given in (µg/L) for Prolactin; in (nmol/L) for Cortisol and Testosterone, in (µmol/L) for Dehydroepiandrosterone sulphate (DHEAS); in (pmol/L) for Estradiol, sensitive (Estradiol) and Thyroxine (T4); 
C-reactive protein, sensitive (CRP) (mg/L); in (mmol/L) for fasting plasma glucose (Glucose), fasting plasma cholesterol (Cholesterol) and high-density lipoprotein (HDL); no unit for low density lipoprotein/high-
density lipoprotein ratio (LDL/HDL ratio), and given in (nmol/d) for 24 hours’ urine collection of Epinephrine (U-epinephrine) and 24 hours’ urine collection of Cortisol (U-cortisol). b T-test for comparisons in each 
group when normally distributed difference and Bonett-Price when the difference is skewed. Significant (<0.05) p-values in bold underlined and trend (p-values (≥0.05–0.2) in bold only. c In DHEAS and in 





Within-group treatment effectb 
 ALL, n=71–79c, d TY, n=24–26 MBCT, n=24–27 CBT, n=23–26 
 P  (CI) P (CI) P (CI) P (CI) 
Prolactin       0.077 –0.85 (–1,79; 0.09)e 
         
Cortisol        0.009 –84.65 (–146.62; 22.69) 
         
DHEASc     0.002 –0.40 (–0.65; –15)e   
          
Testosteroned  <0.001 –0.15 (–0.20; –.10) 0.077 – 0.08 (–0.17; 0.01) <0.001 –0.22 (–0.32; –0.12) 0.024 –0.13 (–0.24; –0.02) 
         
Estradiolc  <0.001 48.5 (26.00; 1.00)e     <0.001 79.00 (43.64; 114.36)e 
         
T4        0.090 –0.46 (–1.00; 0.08) 
         
CRP      0.19 0.06 (–0.03; 0.15)e   
         
Glucose 0.007 0.13 (0.03; 22) 0.089 0.15 (–0.03; 0.33) 0.036 0.14 (0.01; 0.27)   
         
Cholesterol        0.17 0.20 (–0.91; 0.49) 
         
HDL  0.071 0.05 (0.00;.10)       
         
LDL/HDL ratio    0.054 –0.20 (–0.40; 0.00)     
          
         
U-epinephrine  0.012 –4.09 (–7.25; –94) 0.20 –4.64 (–11.92; 2.64) 0.012 –5.43 (–9.55; –0.31)   
         
U-cortisol      0.20 –8.54 (–21.96; 0.89)   
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4.3.2  Article IV, ACTH stimulation test 
In the ACTH stimulation test the majority of maximum responses in serum and saliva were 
found at 30 and 40 min (Figure 7).  
Figure 7 Maximum responses in serum and saliva at 20 to 60 minutes. 
 
When the 30 and 40 min times were calculated together, 30 out of 36 stimulations in serum 
and 29 out of 36 stimulations in saliva resulted in a maximum response after 30 or 40 min. 
Two additional stimulations, both in serum and in saliva, resulted in values after 30 or 40 min 
that were close to the maximum response value, with differences of 1.5 and 3.6 nmol/L in 
serum (0.2% and 0.5% difference) and 0.2 and 0.4 nmol/L in saliva (0.3% and 0.8% 
difference). Thus, 32 stimulations in serum and 31 in saliva had a maximum response or a 
response close to the maximum response after 30 or 40 min. No differences between 
sampling at 30 and 40 min compared to sampling at all times were found in serum (P = 0.12) 
or in saliva (P = 0.06), using the Fisher-Pitman permutation test. This indicates that sampling 
only at 30 and 40 min after stimulation was adequate for recording an individual’s maximum 
response. The response values at 30 min were equal to the response values at 40 min both in 
serum (P = 0.78) and in saliva (P = 0.85), with a median difference of 0.1 nmol/L in serum 
and 1.1 nmol/L in saliva. 
Parallel concentration curves 
The concentration curves of cortisol in serum and in saliva were parallel at 30 and 40 min 
when calculated with GEE. In other words, salivary cortisol could replace serum cortisol in 
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0.90) (Figure 8). Moreover, median cortisol concentrations were similar at 30 and 40 min for 
all participants, both in serum and in saliva (Table 2 and Figure 2) 
Taken together, these findings suggested that sampling in saliva instead of serum at 30 and 40 
min would be a reliable alternative for assessing an individual’s maximum response after 
stimulation. 
Furthermore, the medians of the maximum response values at 30 and 40 minutes were equal 
if the medians of the maximum response values were calculated at all times, P = 0.1 and P = 
0.06, respectively. Cortisol concentration curves were parallel in serum and saliva at 30–40 
min, P = 0.83.  
 
Figure 8  Cortisol concentration curves over time for logarithmically  





5.1 Main findings 
Subjective measures: In this thesis the CBG were mostly women with high education, and 
were on sick leave due to job-related causes. They had a global decrease, comprising all areas 
of life covered by SWED-QUAL subscale scores. Their scores were lower than the HCG, and 
lower than or on a par with persons with severe psychiatric illness and chronic somatic 
diseases with psychiatric comorbidity. This indicates the severity of the situation, given that 
they recently had been healthy. The effect on HRQoL after 20 weeks’ psychological group 
treatment was significant in 10 subscales in TY and in 7 subscales in MBCT and CBT, 
respectively, with normalized scores in many subscales in all groups. The largest 
improvements were seen in main domains known to be affected in burnout/CB and are 
probably due, at least in part, to the treatment. Better effect from treatment was seen in 7 
subscales in favour of TY, with small effect sizes. Objective measures: The 23 biomarkers in 
blood and urine measured at baseline did not show any pathological concentrations according 
to current reference values. When compared to the concentrations of the HCG (20 
biomarkers), the baseline concentrations of urinary catecholamines, 5-HIIA and cortisol were 
significantly lower and could potentially act as markers in future research. After treatment 
several potential markers were found that may be used to follow the course of CB, for 
evaluating psychological treatment in general or in one or more of the three treatment groups, 
such as testosterone, estradiol and urinary epinephrine. The 1 µg ACTH stimulation test can 
be used as a stress-test with sampling in saliva at 30 and 40 minutes, in saliva solely. 
5.2 Socio-demographic data 
The CBG was a clinical sample chiefly from primary health care centres, with a wide variety 
of professions, representing the situation in primary care where most of these patients initially 
are found. They were severely ill, on sick leave and they all had a concomitant depression 
and anxiety, which further aggravated their situation. Few clinical studies have been 
conducted in this patient group, which makes comparisons difficult. Moreover, burnout is 
most often evaluated by questionnaires, primarily MBI, and it is not known what scores 
might correspond to CB. This further complicates comparisons. Another factor is that most 
studies consider only work-related causes of burnout while the CBG studied in this thesis are 
diagnosed according to ICD-10 code F43.8 A, ES. ES also takes into account personal 
reasons for becoming ill, which was the sole cause in approximately 20% of the patients in 
the CBG, and as a part of the cause for being ill in another 41%.  
The CBG had higher education than in the general population, but persons with higher 
education are known to have better health in common. However, the findings might be due to 
higher education opening opportunities for different types of occupations, with other work 
tasks and types of employment, which might lead to an increased risk of CB. Persons with 
lower education may have a higher total workload from work and home taken together, may 
  55 
experience less social support, or may be too sick to manage to participate in treatment. The 
patients in the CBG had applied to take part themselves, mostly after they had received 
information at the primary health care centre; this indicates that they were highly motivated 
for treatment, which predicts a better outcome [146] . 
All reported satisfaction with and effect from the treatment despite the fact that many patients 
at the inclusion interview had said that they actually wanted one of the other treatments. This 
is a more positive evaluation than expected but partly in line with previous research, which 
has shown that treatment works better if the participant is positive to the selected treatment, 
either based on their own wish or if they intellectually have understood and agreed with the 
underlying principle of the treatment, and actively participate in the treatment [146]. Here, at 
the interview they received a detailed description of each of the three treatment arms, which 
would have helped them to understand and agree with the treatment principles, and might 
explain their general satisfaction with the treatment. Besides, the discrepancy here might be 
due to the duration of the treatments, 20 weeks, which gave them time to establish new 
behaviours and get used to the exercises, enabling them to experience for themselves that the 
treatment worked, and because they were asked at the end of the treatment. Moreover, many 
patients request longer treatments. For example, in a recent study in a somewhat similar 
patient group, the patients were randomized to two groups. They received 6 and 2 sessions 
respectively over 12 weeks, and many patients reported that they would like to have more 
sessions/longer treatment. (Personal communication, Anna Nager, 3 December 2019). 
Furthermore, many reported that they had not been offered any other treatment at the primary 
healthcare centre, even though they were severely ill. In this situation, they might have seized 
the opportunity to receive treatment irrespective of whether the treatment was their first 
choice or not. Together, this could indicate that it is possible to influence several factors that 
are important for achieving a good outcome. 
Few men applied to and participated in the study, and few men are diagnosed with CB; 
however, the number of men on sick leave for CB is increasing [2]. Men also tend to report 
less depression [147]. Explanations for this include the fact that women take more care of the 
home and children and are thus under more pressure than men; however, in the younger 
generation of today, many men take more responsibility in the family and are thus more 
likely to receive a CB diagnosis. The Swedish Work Environment Authority found recently 
that when men and women have the same work tasks, the amount of sick leave taken is the 
same [148]. A similar conclusion was drawn in a study based on descriptive data from the 
WHO MONICA study [149]. This study shows that about 13% of the study population 
(n=1000) which comprised healthy working individuals, with slightly more men, had a score 
> 4.0 on the Shirom Melamed Burnout Questionnaire which indicate CB. Shirom Melamed 
Burnout Questionnaire has been shown in other studies to be equivalent to a diagnosis of CB 
(ES) over a certain score. In working individuals in primary care, n= 345, the number of 
individuals indicating ES was 20% with approximately twice as many women as men [150]. 
Furthermore, several sectors dominated by female occupations have been subject to 
downsizing in the last few decades, resulting in a more pressed working situation, and more 
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women likely to be given a CB diagnosis. On the other hand, a recent study found partially 
reversible changes in different brain structures involved in stress processing, with more 
pronounced changes in women after equally perceived stress, indicating an increased 
sensitivity to stress in women [73]. 
5.3 Subjective measures, HRQoL 
At inclusion, the CBG had lowered median scores in all subscales, thus affecting all areas of 
HRQoL; this has not been demonstrated before and highlights the severity of their situation. 
The scores were compared to the HCG group comprised of healthy working persons 
experiencing stress. Their situation had been very similar to that of the CBG until quite 
recently, and they were therefore considered to be a suitable comparison group. Despite the 
fact that the CBG had quite recently become ill, and that they were otherwise healthy, they 
had significantly lower median subscale scores than the HCG. The scores for the CBG were 
on par with or, for some subscales, even lower than for persons with severe psychiatric illness 
or chronic somatic disorders with psychiatric comorbidity [77, 78]. This was unexpected. 
Previous research has shown a somewhat similar pattern, with subscale scores lower than 
expected in a group of healthy persons in a course setting, reporting stress and a wish to 
change their lives [133]. In general, in both mental and somatic chronic diseases, there tends 
to be a habituation to the situation. Patients find ways to lead a reasonably good life with their 
illness, which can make subscale scores relatively higher. This indicates a better HRQoL than 
if the condition had onset recently. When the scores of the CBG were compared with the 
scores of a group of borderline patients, with at least two previous suicide attempts and in 
hospital after exacerbation of symptoms, the scores were on a par or, for some subscales, 
even lower [78]. The CBG had recently been leading a normal life, and probably had their 
usual concept of health fresh in their mind. On the one hand, poor sleep as experienced by 
these patients means that they tend to judge their situation more negatively due to emotional 
bias; this could, to some extent, have affected the subscale scores [151]. On the other hand, 
psychiatric patients have been shown to be credible reporters of their HRQoL [75].  
5.3.1 Physical well-being  
The subscale scores at baseline for “physical function” were comparatively high in all three 
groups, most probably because the patients were previously healthy and of an age with low 
concomitant morbidity. In a previous study, the same trend was seen in healthy individuals 
experiencing emotional ill-health and attending a mind-body-medicine course [133]. Other 
studies have shown that, initially, physical function is less affected in stressful situations 
compared to cognition and emotional well-being [152]. The other subscales on physical well-
being showed an inconsistent pattern between the groups, with improvement in some 
subscales but not in others, despite the large improvements in emotional well-being. 
Individuals with burnout are more prone to negative affect and usually report a decline in 
mental health and somatic symptoms [153]. Furthermore, there is an inconsistent association 
between negative affect and objectivity when reporting health status [154]. Previous research 
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has found that high burnout, especially in persons scoring high on the emotional exhaustion 
component of MBI, corresponded to low HRQoL both mentally and physically [155]. In 
addition, a recent report on burnout suggests that physical health is also affected negatively in 
CB [156]. Taken together, we expected physical health to improve simultaneously with an 
improvement in emotional well-being. In TY, physical work in the form of gentle yoga 
movements was used together with awareness training, and this could have given the 
participants an accurate idea of their capacity and physical function. The subscale “physical 
functioning” showed a non-significant increase while the subscale “role limitation due to 
physical health” showed a significant improvement. As “physical functioning” also contains 
questions about physically demanding work, while “role limitation due to physical health” 
deals with the day-to-day situation in which the person is normally involved irrespective of 
how they feel, the improvement might have been experienced earlier. In the elderly at risk of 
cardiovascular disease, gentle yoga was found to improve the overall physical function and 
capacity in 83% of the participants [157]. The median scores for “physical functioning” in the 
CBT treatment group did not change, most probably because they had a high baseline 
subscale score. Relaxation was part of the CBT treatment in order to increase bodily 
awareness and, together with the cognitive strategies, was used to counteract the effects of 
burnout. However, it appeared not sufficient to improve “physical functioning”. In previous 
research, CBT improved physical function in patients on sick leave for stress-related 
disorders, which is in contrast to our results. That study used SF-36, an HRQoL questionnaire 
similar to SWED-QUAL; however, the baseline scores were not reported in that study, which 
might explain this discrepancy [158]. All three groups reported a low, non-significant 
increase in scores in the subscale “pain”, together with low, no and medium effect sizes in 
TY, CBT and MBCT, respectively, which was not anticipated. We had expected an 
improvement after treatment because pain is often an early symptom in stress-related 
disorders. On the other hand, perhaps because pain is a non-specific symptom it is the last of 
the symptoms to disappear. Because MBCT showed a significant increase in “physical 
functioning” we assumed it would affect the subscale “pain”; the low increase seen with TY 
might be due to the bodywork in the treatment which enabled them to come into contact with 
their physical pain and better assess it. 
5.3.2 Emotional well-being and cognitive function 
Emotional well-being comprised the subscales “negative affect”, “positive affect” and “role 
limitation due to emotional health”. This is the domain in which the largest improvements 
were observed. The improvements were found both when all groups were calculated together 
and when the groups were analysed separately (Table 7 + Figure 6). The effect from TY 
might be due to the fact that the participants tried to be aware of their bodily sensations and 
their emotions together with the rhythmic, regular breathing, and the gentle physical 
movements [159, 160]. These components have previously shown an effect on the autonomic 
nervous system, both the sympathetic and the parasympathetic systems, as well as on positive 
and negative emotions (affect) [106, 161, 162]. As TY uses a holistic approach, employing 
exercises from physical, emotional and cognitive domains in each exercise, this may have 
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enhanced the improvement in the emotional domain. In previous research CBT has also 
shown an effect on positive and negative affect [163, 164]. Cognitive function and emotions 
are closely connected, and there is a mutual influence. In burnout, memory, the ability to 
concentrate, the capacities to understand and to focus on day-to-day life are important aspects 
of cognitive function which are often compromised. Here, all three groups had a similar 
improvement in cognitive function although the methods were quite different, especially in 
the TY group which trained cognitive function in a different way from MBCT and CBT. This 
opens up possibilities to treat individuals that for various reasons cannot attend CBT or 
MBCT. This is in line with research in children diagnosed with ADHD who had improved 
day-to-day skills with an increased ability to focus and concentrate as well as increased social 
skills after yoga [165]. Cognitive function has also been shown to improve in breast cancer 
patients after yoga [166], and in menopausal women [167]. Furthermore, a large number of 
studies have shown that CBT has a good effect on various aspects of cognitive function, 
which is in line with our findings [33, 157]. 
5.3.3 Sleep   
In all three groups the subscale “sleep” showed significant improvements. In previous 
studies TY is reported to have an effect on sleep, which may be due to the overall stress-
reducing effect, relaxing, decreased negative effect and an improvement in body awareness. 
Yoga has in previous studies shown an impact on sleep disturbances, which support our 
findings. As sleep is known to be a crucial factor in the development of burnout the 
improvement might have helped to ameliorate the burnout symptoms. In a recent study 
improvement in sleep quality was one of the mediating factors in reduced symptoms of 
exhaustion [34]. CBT is a common therapy for sleeping problems, and has previously 
shown good effect in a group of depressed patients experiencing insomnia, which supports 
our findings [168]. TY showed a trend for a better effect than did CBT in the subscale 
“negative affect”. This is in line with our hypothesis but additional studies are needed to 
explore this. 
 
A general increase in HRQoL is not necessarily followed by an increase in work ability, but 
an improvement in the scores of subscales “role limitation due to emotional health” and 
“role limitation due to physical health” may indicate an increased capacity to work. These 
two subscales reflect how our role functions in life and at work are affected by how one 
feels physically and emotionally. Both TY and CBT showed large improvements in these 
subscales. Previously, some studies have been able to show increased return to work, lower 
sick leave or remission, using CBT as a stand-alone treatment or in combination with work-
place interventions [7, 124, 169], but usually the treatments have been shorter (8–16 weeks) 
[10], and the effect sizes are often small. When the scores after treatment in TY and CBT 
were compared with the scores of HCG [131], both showed decreased median differences. 
The difference in subscale scores was no longer significant in ten subscales in the TY 
group, and in five subscales in the CBT group after median regression (data not shown). 
This might indicate a good effect of the treatment.  
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5.4 Objective measures, biomarkers 
5.4.1 Biomarkers at baseline 
None of the 23 biomarkers in the CBG showed a pathological level before treatment, i.e. had 
a concentration outside the current reference ranges. This is in accordance with earlier 
studies. Previous research has shown that biomarker concentrations at baseline are 
significantly higher or lower in stressed individuals than in non-stressed individuals and, with 
rare exceptions, within the reference range. However, we do not know whether these 
reference ranges can be applied in this setting or whether a low or high concentration within 
the reference range may be interesting in this group of patients. 
The study in the CBG is one of the few studies that have explored biomarker concentration 
before and after well-defined psychological treatment in patients diagnosed with a medically 
certified diagnosis, ES, ICD-10 code F43.8A (Table 1). This means that direct comparison 
with previous research becomes difficult. In one study, patients were diagnosed based on 
psychometric rating scales, symptom scales and standardized medical examination and 
another used the ICD-10 code Z73.0. The ICD-10 group of Z-codes is defined as “Factors 
influencing health status and contact with health services”, and these do not have any 
diagnostic criteria. The code Z 73.0, “State of vital exhaustion” was occasionally used to 
diagnose CB before ES was established, but direct comparisons with the CBG become 
difficult, which might explain some of the differences found here, for example concerning 
CRP, cortisol, HbA1c and u-epinephrine. 
5.4.2 Comparison of the clinical burnout group, (CBG) with healthy working 
individuals experiencing stress (HCG) (III) 
Cortisol 
The adrenal hormone cortisol showed a trend (p=0.071) for a higher concentration in the 
CBG. In previous research, inconsistent results have been found, with decreased, increased or 
equal concentrations at baseline both in patients with “high burnout”, i.e. severe burnout 
measured by psychometric instruments, and in patients with CB and other stress-related 
illness [69, 170, 171]. This might be due to “timing” i.e. the duration of the stress-related 
illness. How long the person has been sick is a crucial factor for the interpretation of the 
cortisol concentration when evaluating the level of burnout. This has been highlighted by 
several authors and could explain the contradictory results [62-64]. 
Adrenal and ovarian hormones 
The adrenal and ovarian hormones estradiol, testosterone and their binding protein SHBG did 
not show any significant differences in concentration compared to the HCG. Testosterone 
showed a non-significant higher concentration. In a previous study a similar picture was seen, 
with significantly higher testosterone concentrations in persons on sick leave for affective 
stress-related mental disorders, compared to healthy people. When the results in that study 
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were compared to healthy individuals experiencing stress the increase was small, and non-
significant, as in our study [172] . 
Biomarkers for inflammation, and lipid and glucose metabolism 
Lower levels of glucose and HbA1c were found in the CBG than in the HCG. Previous 
studies have shown higher HbA1c levels in persons with burnout [173, 174]. Both these study 
populations had milder burnout than those in the CBG. 
Urinary hormones measuring stress 
The 24-hour urine collection for the urinary hormones u-5HIAA, u-epinephrine, u-
norepinephrine, u-dopamine and u-cortisol showed a significant difference for all hormones 
between the CBG and the HCG (Table 9). This might indicate that these hormones can be 
used as markers when studying CB in patients. In the CBG, all the urinary hormones showed 
higher secretion over 24 hours, except cortisol which showed a lower secretion. This was 
expected as the study group had been on sick leave for more than 12 weeks prior to the 
baseline measurements. Furthermore, they had experienced stress for a long period of time 
before being put on sick leave. Taken together, high u-catecholamines and low u-cortisol 
secretion was expected. In previous research, results have been contradictory. Moch et al. 
2003 found lower u-cortisol in a group of burnout patients, even below the reference range, 
while there was no significant difference in the concentration of u-catecholamines [175]. In 
contrast, Traunmüller et al. 2018 found a lower concentration of u-norepinephrine, but not u-
epinephrine, in persons diagnosed with burnout compared to a control group of healthy 
individuals working full-time [176]. The explanation could be that acute stress is high when 
working and dealing with a difficult situation, whereas the stress diminishes when on sick 
leave. A significantly higher concentration of u-5HIAA was found for the CBG compared to 
the HCG. Previous research has shown that patients with depressive disorder and stress, as in 
the CBG, have increased u-5HIAA which could explain the findings [177]. Furthermore, 
stress often precedes depression, and severe stress and depression often coexist in CB [21]. 
5.4.3 Hormonal changes after treatment within the CBG, n=71–79 
The main effect was found in testosterone and in estradiol, both anabolic hormones, as well 
as in u-epinephrine. Testosterone decreased after treatment. Previous research has shown that 
middle-aged premenopausal women with chronic stress have higher u-testosterone than non-
stressed women [178]. In another study testosterone was high in women on sick leave for 
psychosocial disorders, compared to healthy individuals [172]. Furthermore, exogenous 
testosterone has been shown to attenuate the integrated central stress response in healthy 
women [179]. In yoga studies, testosterone secretion in saliva increased after a single session 
of yoga in 23 healthy middle-aged and older women [180], and serum testosterone decreased 
in an RCT (n=90), after a holistic 12-week programme in women with polycystic ovarian 
syndrome [181], which is in line with our findings. This may indicate that testosterone is 
increased to mitigate the effect of stress, and thus decreases with a lowered level of stress, as 
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in our CBG. Besides, the concentration of testosterone is said be altered by yoga according to 
Hatha yoga pradipika, but how and in what way is not described [82]. In our study we could 
not determine whether the lowered testosterone was due to an impact on the adrenals, the 
ovaries, or on both. Estradiol measured in saliva has previously been shown to decrease in 
young women with elevated psychological stress, which is in line with our results [182]. As 
95% of the estradiol is produced in the ovaries [183] we assume that the increased level after 
treatment was due to less suppression of the ovaries. Few studies have examined biological 
biomarkers after treatment especially in this well-defined, diagnosed group of CB patients. 
Moch et al. 2003 showed that prolactin, ACTH, u-cortisol, s-cortisol, DHEAS, glucose, TG, 
cholesterol, LDL, HDL, u-epinephrine and u-norepinephrine did not change after a 1–2-week 
stress management intervention programme [175]. The programme comprised diet, exercise 
and behaviour modification for 5–10 consecutive days. Follow-up was carried out monthly 
for 4 months. This is in line with our findings, except for u-epinephrine, although their 
treatment was shorter and their study population was small, n=16. Previously, cortisol has not 
shown any change after treatment when the cortisol awakening response was measured [184] 
and no change in diurnal serum cortisol secretion [185]. In another study DHEAS was shown 
to predict the development in health: an increase after treatment indicated a larger decrease in 
CB symptoms than for patients with a decrease in DHEAS concentration [186]. We could not 
verify their results since no comparison with burnout symptoms was made in our study.  
5.4.4 Comparison within each treatment group n=23–27 
Although biomarkers for measuring the effect of psychological treatment in general have not 
been established yet, we also studied the treatment effect in each of our treatment groups, to 
find out if differences in effect appeared. Here all three groups showed a decrease in 
testosterone, with a significant difference for MBCT and CBT and a trend in TY. Estradiol 
showed an increase in CBT. No previous studies have shown an effect on these anabolic 
hormones after treatment in patients with CB.  
The most significant differences in biomarkers were found in MBCT and in CBT, while TY 
had several trends but no significant differences in biomarker concentrations. Why TY did 
not show an effect on a par with CBT and MBCT in this setting is noteworthy. All three 
treatment groups had a good effect on HRQoL [187]. Why the TY showed less effect on 
biomarkers remains to be elucidated. Concerning the biomarkers we at least know that the 
markers found can be explored in further research to follow the course of CB. 
5.4.5 Comparison with other studies in similar patient groups 
Previous studies in patients with CB have shown effects from psychological and stress-
reducing interventions with our without workplace interventions, on psychological 
symptoms and QoL [7, 123], mostly shown marginal effects on sickness absenteeism and 
return to work [7] but also on burnout [188]. We cannot know for sure whether the changes 
found here in HRQoL and biomarkers are from the treatment, from time, i.e. a natural 
healing, from other factors like self-efficacy and intention to go back to work, or a 
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combination. However, a recent clinical study in patients with CB and diagnosed with ES 
showed significant improvement in return to work after rehabilitation, compared to wait-list 
controls at the one-year follow-up . These patients had been on sick leave for a mean of 
seven months, and a maximum one year at inclusion, which is slightly shorter than for our 
CBG. The authors concluded that the control group situation probably reflected the natural 
course of CB [126]. This indicates that treatment might have an effect in these patient and 
that healing is not just a matter of time, which has been proposed previously [7]. In another 
study, patients with CB showed a significant improvement after self-help combined with 
CBT face-to-face in a second step, compared to only self-help [169]. The CBT treatment in 
that study was disease specific and the results indicates that CBT as a stand-alone might 
help this group of people when a CBT protocol is used which is adapted to the patient 
group, as in our study. In another study, patients on sick leave and with adjustment 
disorder, received CBT alone or in a combination with integrated work aspects. Self- 
efficacy was measured at baseline and after 12 sessions with a therapist. Partial return was 
faster in the combined group and irrespective of level of self-efficacy, while full return to 
work was achieved to a higher degree in patients with high self-efficacy at baseline. This 
indicates that an individual evaluation of each patient should be performed and extra 
support in certain areas can give a better outcome. Moreover, with prolonged sick leave on 
full time, as in our CBG, and without much improvement, a rapid, spontaneous recovery 
becomes less probable. Furthermore, as these patients are at high risk of relapse, the 
treatments might help to increase the awareness of patterns and behaviours and give tools to 
better handle the work situation and life after the treatment period, which might reduce the 
risk of relapse. This is especially important as the risk of future sick leave and disability 
pension increases with repeated exposure to sick leave, as well as after long-term sick leave 
[189]. Furthermore, burnout is known to predict permanent work disability [190].  
5.5 Objective measures, the intravenous 1 µg ACTH test 
Sampling in saliva at 30 and 40 min is sufficient to reliably measure the maximum cortisol 
concentration following a 1μg ACTH test in a healthy population. Sampling both in serum 
and in saliva at only 30 and 40 min after the 1μg ACTH stimulation could be sufficient to 
record the maximum numerical response of an individual (figure 5). In addition, parallelism 
in the concentration curves of serum and salivary cortisol at 30 and 40 min (P = 0.82 and P = 
0.90 for raw data and raw data transformed into natural logarithms) ( Figure 6) implies that 
sampling in saliva could reliably replace sampling in serum in the 1μg ACTH test. The 1μg 
ACTH stimulation test has been used mainly in clinical, endocrinological settings to evaluate 
disturbances of the HPA axis and to diagnose somatic diseases. Since the HPA axis also 
mediates the body’s response to a stress stimulus, the 1μg ACTH test may yield valuable 
information about an individual’s ability to respond to stressful stimuli and provide a means 
to evaluate therapeutic psychological treatments and recovery. Based on our findings, 
sampling at 30 and 40 min would suffice to determine the maximum response, which would 
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be the highest value of the two samples. In addition, sampling only twice and only in saliva 
would be an alternative that is cost-effective, faster, and with non invasive sampling. 
Previous studies have shown that stress may alter the function of the HPA axis, with altered 
cortisol secretion as an outcome following a DEX-CRH test, ACTH test, insulin-induced 
hypoglycaemia or standardized meal [25, 191, 192]. These findings support our proposal to 
use the ACTH test to diagnose stress-related disorders such as adjustment disorder and 
burnout, and to evaluate recovery and treatments. However, sampling, chiefly in plasma or 
serum but also in saliva, and at multiple times, is difficult to do in clinical practice or in large-
scale studies. Our suggestion of using the 1μg ACTH test to sample in saliva and only twice 
would be an attractive alternative. The correlation between salivary and serum cortisol 
concentrations observed here has been reported earlier [193, 194], but no other study has 
shown that serum and salivary cortisol concentration curves were parallel at 30 and 40 min 
following ACTH stimulation, when the maximum response occurs, which supports the 
proposal to replace sampling in serum with sampling in saliva. Cortisol sampling in saliva 
instead of serum following stimulation tests with 1μg ACTH in healthy participants is in 
accordance with previous studies on both healthy participants and participants referred to 
endocrinological investigation with or without endocrine diagnoses [195, 196]. By contrast, 
Schindhelm et al. 2010 showed that sampling in saliva did not meet the criteria for sensitivity 
and specificity which sampling in serum or plasma did [197]. The Schindhelm study included 
51 patients referred to ACTH testing as part of an endocrinological investigation to diagnose 
primary and secondary adrenal insufficiency, and sampling was performed only at baseline 
and at 30 min. When the test is used as a diagnostic tool, cortisol concentration should reach a 
value above the ≥ 500 nmol/L or ≥ 550 nmol/L cutoffs, depending on assay and sample time. 
Thus, the exact concentration value of the maximum response is not of interest. In stress 
research, however, where one is interested in the adrenal responsive capacity before and after 
different types of interventions, the exact value of the maximum response could be of 
interest. Therefore, the results of the study by Schindhelm et al. are not applicable when the 
ACTH test described here was evaluated for stress research. A possible explanation of the 
difference might be that sampling in the study by Schindhelm et al. was performed only once 
after stimulation (Fig. 4).  
5.6 Strengths and limitations in the present dissertation  
One of the strengths is that the CBG was a homogeneous group, and besides self-assessment, 
they were on sick leave for a medically certified diagnosis, using the ICD-10 code Exhaustion 
Syndrome, F43.8A. Furthermore the patients in CBG were recruited mostly from primary 
health care centres and they were a clinic sample with diverse occupations, reflecting the 
situation in occupational medicine and primary care. Few clinical studies were found in this 
particular group of severely sick patients. Strength is randomization to three well-defined 
psychological treatments, especially designed for this specific patient group. The subjective 
measure SWED-QUAL, a HRQoL questionnaire, has been use in several studies in the 
general population and is well validated. The questionnaire is generic, and the 13 subscales 
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allow for more specific analyses than if the questionnaire is global, which constitutes another 
strength in the study. Also, SWED-QUAL is generic and the questions cover many aspects of 
work and life and most components known to be affected in burnout. SWED-QUAL has in 
previous research shown to be stable over time in other patient groups, which might indicate 
that a change in scores reflect a real change [132]. A combination of subjective and objective 
measures was explored, which might give a better picture of the condition of the CBG. The 
objective measures with biomarkers have not been explored previously in this well-defined 
patient group, and before and after treatment. 
Moreover, we used an active control group, which is recommended, as after a long, inactive 
period there are difficulties returning to work. Participating in a wait-list control group might 
mean that we withhold efficacious treatment from patients in need and maybe make it more 
difficult for them to return to their normal life and work. Also, an inactive control group in 
CB patients is rarely inactive, searching for all sorts of support, despite their severe condition, 
thus making it difficult to know what you are actually comparing with [198]. A somewhat 
similar situation emerges when “treatment as usual” is used as comparison because the 
treatment components, if any, may vary considerably. Besides, an inactive control group may 
deteriorate over time [144].  
The limitations were that the number of patients in each treatment was small (n = 26–27).  
Furthermore no evaluation of the adherence to the treatment protocols was made, however, in 
each treatment arm, only one therapist was involved. Also, in most cases the patients were 
supposed to start work or work longer hours after the treatment was completed and many of 
the patients expressed worry and stress for that reason. The blood tests were taken and the 
questionnaire was filled out in this quite stressful situation, which might have influenced the 
results. The majority of the patients in the study were women, reflecting the situation at the 
primary health care centres. We do not know why more women are diagnosed with ES. One 
explanation may be that women often face a double workload with the main responsibility for 
housework. Moreover, a recent study found an increased vulnerability to stress in women, 
with larger structural brain abnormalities than in men in response to the same degree of 
perceived stress [73]. On the other hand, a report from 2014 showed that men are as likely as 
women to receive a diagnosis of ES, given that they have the same work situation [148]. The 
number of men with an ES diagnosis has increased during the past years [199]. In this study 
the group of men was too small to do a separate analysis of biomarker changes in men, and in 
men versus women after the three psychological treatments during ES.[200] 
The patients in the CBG were highly motivated and thus we do not know how the treatment 
would have worked for patients with less or no motivation. Besides, having motivation also 
indicates that they were not the most ill patients. Maybe some patients have a worse condition 
or a social situation that may not give support during treatment, which makes it difficult to 
manage an extensive treatment like the treatments in CBG. Most of the patients reported that 
they previously had applied for but not received treatment for CB. This might mean that 
patients in the CBG, diagnosed with CB, had a more serious condition or more complicating 
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factors than usual in treatment, as at least one of several rehabilitation clinics during that 
period used diverse selection criteria.  
CB is also a complex state which probably includes many factors that we so far do not take 
into consideration when we diagnose and treat these patients, and in Sweden the diagnostic 
criteria are currently under revision (personal communication, Anna Nager, 3 December 
2019). Factors that might influence the process and need to be further explored are, for 
example, the expectancy of future work ability [201], how what you go back to at work 
affects [202], the feeling of self-efficacy [203],  and how work-related reasons and the 
personal situation respectively affect the possibilities to return to work and life. The time also 
seems to be crucial. The importance of prevention has been stressed in many studies. Some 
changes in brain structures involved in stress processing have been shown to be reversible 
while others seem to be prevailing. At what point in the course of longstanding stress and CB 
these changes occur we do not know, nor to what extent they have an impact in a person’s life 
after recovery. Some of these changes are similar to the changes seen in persons with early 
childhood trauma [53], indicating a non reversible condition. This stresses the importance of 
preventing and detecting these persons early and treating these persons before they become 
severely sick. Also, the situation at the workplace is important, and in the Netherlands the 
number of persons sick-listed   has decreased after new regulations were introduced [204] 
together with new guidelines for treatment of AD in primary care and occupational settings 
[205]. Moreover, the companies were given greater responsibility for prevention, 
rehabilitation and financial responsibility for the employees’ sickness benefits [206],  
The results concerning biomarkers are not fully in line with the results for HRQoL. At 
baseline the biomarkers were lowered, but within reference intervals, while HRQoL was 
significantly lowered. Then, after treatment, TY was the treatment with the highest number of 
HRQoL subscales with a significant improvement, but it had no significant increases in 
biomarker concentrations after comparatively long time and treatment. This contradicts the 
hypothesis and warrants further investigation. The 1 µg ACTH test which measures cortisol 
after injection is a potential stress test with sampling only in saliva. 
5.7 Conclusions 
The CBG with patients on long-term sick leave, and diagnosed with CB had a global decrease 
in the subjective measure HRQoL. The scores were on a par with scores in patients with 
severe psychiatric disorder and chronic somatic diseases with psychiatric comorbidity, which 
indicates the severity of the situation for these patients.  
Moreover, psychological treatment with TY, MBCT or CBT in-group showed a significant 
change in the majority of subscales, with the highest number of improved subscales (10 out 
of 13) in TY, and several of the subscales were normalized after the treatment period.  
Probably the improvements are due, at least to some extent, to the treatments. This suggests 
that the treatments can be used to reduce symptoms of stress and to increase HRQoL in 
stress-related disorders in general and more specifically in CB patients. TY seems to be a 
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possible treatment alternative to CBT. When comparing the effect of the treatments, a small 
effect size was found in favour of TY in 7 subscales, indicating a slightly better effect from 
TY in some aspects. The objective measurement with 23 analysed concentrations of 
biomarkers in the CBG showed a significant change compared to the HCG, indicating that 
physiological changes had occurred in these severely sick patients on sick leave, but not to 
such an extent that the biomarkers showed pathological concentrations, according to current 
reference ranges. Twenty-four-hour collection of the urinary hormones u-5HIAA, u-
epinephrine, u-norepinephrine, u-dopamine, u-cortisol and HbA1c all showed a significant 
difference between the CBG and the HCG, and are potential biomarkers for diagnosis.  
After 20 weeks of treatment in the CBG, testosterone, but also estradiol, DHEAS and u-
epinephrine showed a significant difference pre-post treatment, and are potential biomarkers 
to follow the course, probably for evaluation of the effects of psychological treatment in 
general and for one or more of the three treatments, TY, MBCT and CBT groups. This 
remains to be evaluated in further research. 
5.8 Implications for health care and future research  
The results indicate that TY could be used at all levels in the health care system to improve 
HRQoL in stress-related disorders including CB, but more studies are needed with different 
types of control groups including a control group receiving a homogeneous “treatment as 
usual” and a wait-list control, to establish if, and to what an extent, the effects seen here are 
from the treatment.  
It is not likely that a single marker or questionnaire alone can define and diagnose CB. 
Rather, a clinical examination together with biomarkers and questionnaires for burnout and 
HRQoL as well as psychiatric evaluation is probably necessary. 
For treatment a similar situation is probably needed, with treatment components individually 
tailored for each patient, decided on in cooperation with the patient. Psychological treatment, 
physical activity, support for return to work, counselling for a healthy lifestyle concerning 
food, sleep and recuperation are probably necessary for a better balance in life and at work 
and to minimize the risk of relapse.  
In future larger studies, the biomarkers found here can be used as outcome variables, to 
evaluate whether the hypotheses are true. If so, testing of the clinical usefulness of the 
biomarkers found is a possible next step. Furthermore, larger treatment groups are needed to 
ensure statistical significance for a smaller number of chosen parameters to confirm our 
findings. Also, filling out questionnaires and sampling blood and urine several times during 
the treatment and well before the finalizing of the study would be preferable. This should 
lower the risk that the stress of starting to work again or work longer hours influences the 
results. A follow-up period of 6–12 months, with treatment sessions maybe only once a 
month, together with sampling and filling out questionnaires at 6 and 12 months, could help 
to elucidate the effect of treatments on biological biomarkers in the long term.  
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